0001716947 2023-01-01 2023-12-31 0001716947 dei:BusinessContactMember 2023-01-01 2023-12-31 0001716947 2023-12-31 0001716947 2022-12-31 0001716947 2022-01-01 2022-12-31 0001716947 us-gaap:CommonStockMember 2021-12-31 0001716947 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001716947 us-gaap:RetainedEarningsMember 2021-12-31 0001716947 us-gaap:NoncontrollingInterestMember 2021-12-31 0001716947 2021-12-31 0001716947 us-gaap:CommonStockMember 2022-12-31 0001716947 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001716947 us-gaap:RetainedEarningsMember 2022-12-31 0001716947 us-gaap:NoncontrollingInterestMember 2022-12-31 0001716947 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001716947 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001716947 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001716947 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001716947 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001716947 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001716947 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001716947 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001716947 us-gaap:CommonStockMember 2023-12-31 0001716947 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001716947 us-gaap:RetainedEarningsMember 2023-12-31 0001716947 us-gaap:NoncontrollingInterestMember 2023-12-31 0001716947 ENSC:EBIRIncMember 2023-12-31 0001716947 ENSC:EBIRIncMember 2020-12-31 0001716947 ENSC:EBIRIncMember ENSC:KeyPersonnelMember 2023-12-31 0001716947 ENSC:EBIRIncMember ENSC:UnrelatedPartyMember 2023-12-31 0001716947 2023-03-01 2023-03-31 0001716947 srt:MinimumMember 2023-12-31 0001716947 srt:MaximumMember 2023-12-31 0001716947 2021-01-01 2021-12-31 0001716947 2022-07-01 2022-07-31 0001716947 2018-09-30 0001716947 ENSC:YearOneMember 2018-09-30 0001716947 ENSC:YearTwoMember 2018-09-30 0001716947 2019-08-31 0001716947 ENSC:YearOneMember 2019-08-31 0001716947 ENSC:YearTwoMember 2019-08-31 0001716947 ENSC:YearThreeMember 2021-06-30 0001716947 ENSC:YearFourMember 2022-06-30 0001716947 2022-06-30 0001716947 2019-09-30 0001716947 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001716947 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001716947 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001716947 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001716947 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001716947 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001716947 ENSC:ConvertibleNotesMember 2022-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsMember 2022-12-31 0001716947 ENSC:ConvertibleNotesMember 2023-01-01 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsMember 2023-01-01 2023-12-31 0001716947 ENSC:ConvertibleNotesMember 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsMember 2023-12-31 0001716947 ENSC:MPARMember 2023-01-01 2023-12-31 0001716947 ENSC:MPARMember 2022-01-01 2022-12-31 0001716947 ENSC:TAAPOUDMember 2023-01-01 2023-12-31 0001716947 ENSC:TAAPOUDMember 2022-01-01 2022-12-31 0001716947 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001716947 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001716947 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001716947 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001716947 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001716947 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001716947 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-12-31 0001716947 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001716947 2020-12-31 0001716947 us-gaap:InvestorMember 2021-06-30 0001716947 us-gaap:InvestorMember 2023-12-31 0001716947 us-gaap:InvestorMember 2021-06-01 2021-06-30 0001716947 us-gaap:InvestorMember ENSC:FirstAnniversaryMember 2021-06-01 2021-06-30 0001716947 us-gaap:InvestorMember ENSC:EighteenMonthAnniversaryMember 2021-06-01 2021-06-30 0001716947 ENSC:JulyTwentyTwentyTwoMember us-gaap:CommonStockMember 2022-07-01 2022-07-31 0001716947 ENSC:JanuaryTwentyTwentyThreeMember us-gaap:CommonStockMember 2022-07-01 2022-07-31 0001716947 ENSC:InvestorsMember 2021-07-01 2021-07-31 0001716947 ENSC:InvestorsMember 2021-07-31 0001716947 ENSC:TwentyTwentyThreeNotesMember 2023-12-31 0001716947 ENSC:FinancedInsuranceMember 2023-12-31 0001716947 ENSC:TwentyTwentyTwoNotesMember 2022-12-31 0001716947 ENSC:FinancedInsuranceMember 2022-12-31 0001716947 ENSC:TwentyTwentyThreeNotesMember 2023-01-01 2023-12-31 0001716947 ENSC:TwentyTwentyOneNotesMember 2021-09-24 0001716947 ENSC:TwentyTwentyOneNotesMember 2021-09-23 2021-09-24 0001716947 ENSC:TwentyTwentyOneNotesMember 2021-11-05 0001716947 ENSC:TwentyTwentyOneNotesMember 2021-11-04 2021-11-05 0001716947 ENSC:TwentyTwentyOneNotesMember 2023-01-01 2023-12-31 0001716947 ENSC:TwentyTwentyOneNotesMember 2022-01-01 2022-12-31 0001716947 ENSC:TwentyTwentyTwoNotesMember 2022-06-30 0001716947 ENSC:TwentyTwentyTwoNotesMember 2022-06-28 2022-06-30 0001716947 ENSC:TwentyTwentyTwoNotesMember us-gaap:CommonStockMember 2022-06-30 0001716947 ENSC:TwentyTwentyTwoNotesMember 2022-01-01 2022-12-31 0001716947 ENSC:TwentyTwentyOneNotesMember 2022-06-30 0001716947 ENSC:TwentyTwentyTwoNotesAndTwoThousandTwentyOneMember 2023-05-12 0001716947 ENSC:TwentyTwentyOneNotesMember 2023-05-12 0001716947 ENSC:TwentyTwentyTwoNotesMember 2023-12-31 0001716947 srt:MaximumMember ENSC:TwentyTwentyTwoNotesMember 2023-01-01 2023-12-31 0001716947 srt:MinimumMember ENSC:TwentyTwentyTwoNotesMember 2023-01-01 2023-12-31 0001716947 ENSC:TwentyTwentyTwoNotesMember ENSC:LetterAgreementMember 2023-01-12 0001716947 ENSC:TwentyTwentyTwoNotesMember ENSC:LetterAgreementMember 2023-05-12 0001716947 ENSC:TwentyTwentyTwoNotesMember 2023-01-12 0001716947 2023-05-12 0001716947 ENSC:SecuritiesPurchaseAgreementMember 2023-10-22 2023-10-23 0001716947 ENSC:TwentyTwentyThreeNotesMember ENSC:SecuritiesPurchaseAgreementMember 2023-10-22 2023-10-23 0001716947 ENSC:TwentyTwentyThreeNotesMember ENSC:FirstClosingSecuritiesPurchaseAgreementMember 2023-10-25 0001716947 ENSC:TwentyTwentyThreeNotesMember ENSC:FirstClosingSecuritiesPurchaseAgreementMember 2023-10-24 2023-10-25 0001716947 ENSC:TwentyTwentyThreeNotesMember ENSC:SecondClosingSecuritiesPurchaseAgreementMember 2023-11-29 0001716947 ENSC:TwentyTwentyThreeNotesMember ENSC:SecondClosingSecuritiesPurchaseAgreementMember 2023-11-29 2023-11-29 0001716947 ENSC:TwentyTwentyThreeNotesMember ENSC:SecuritiesPurchaseAgreementMember 2023-10-23 0001716947 ENSC:SecuritiesPurchaseAgreementMember 2023-10-23 0001716947 ENSC:TwentyTwentyThreeNotesMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001716947 2023-06-01 2023-06-30 0001716947 ENSC:FinancedInsurancePremiumsMember 2023-01-01 2023-12-31 0001716947 ENSC:FinancedInsurancePremiumsMember 2022-01-01 2022-12-31 0001716947 2021-09-24 0001716947 2021-11-05 0001716947 srt:MinimumMember ENSC:TwentyTwentyOneNotesMember 2021-09-24 0001716947 srt:MaximumMember ENSC:TwentyTwentyOneNotesMember 2021-09-24 0001716947 ENSC:TwentyTwentyTwoNotesMember 2022-07-31 0001716947 srt:MinimumMember ENSC:TwentyTwentyThreeNotesMember 2023-11-29 2023-11-29 0001716947 srt:MaximumMember ENSC:TwentyTwentyThreeNotesMember 2023-11-29 2023-11-29 0001716947 ENSC:PrefundedWarrantMember 2022-12-07 0001716947 us-gaap:CommonStockMember 2022-12-07 0001716947 us-gaap:WarrantMember 2022-12-07 0001716947 ENSC:CommonWarrantOneMember 2022-12-07 0001716947 ENSC:CommonWarrantTwoMember 2022-12-07 0001716947 ENSC:CommonWarrantMember 2022-12-07 0001716947 2021-06-30 0001716947 2023-08-31 0001716947 srt:MinimumMember 2021-06-30 0001716947 srt:MaximumMember 2021-06-30 0001716947 2021-06-30 2021-06-30 0001716947 ENSC:PublicWarrantMember 2021-06-30 0001716947 ENSC:PrivateWarrantMember 2021-06-30 2021-06-30 0001716947 us-gaap:SubscriptionArrangementMember 2021-08-03 0001716947 2021-08-03 0001716947 2021-07-02 0001716947 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-02 0001716947 srt:MinimumMember 2021-09-24 0001716947 srt:MaximumMember 2021-09-24 0001716947 2022-07-01 0001716947 2022-08-09 0001716947 ENSC:DecemberPublicOfferingMember 2022-07-01 0001716947 ENSC:DecemberPublicOfferingMember 2022-08-09 0001716947 us-gaap:WarrantMember 2023-05-12 0001716947 us-gaap:WarrantMember 2022-12-09 0001716947 us-gaap:WarrantMember 2023-02-06 0001716947 srt:MinimumMember us-gaap:WarrantMember 2023-02-06 0001716947 srt:MaximumMember us-gaap:WarrantMember 2023-02-06 0001716947 srt:MinimumMember us-gaap:WarrantMember 2023-05-12 0001716947 srt:MaximumMember us-gaap:WarrantMember 2023-05-12 0001716947 ENSC:SeriesAOneWarrantMember 2023-05-12 0001716947 ENSC:SeriesATwoWarrantMember 2023-05-12 0001716947 ENSC:PlacementAgentWarrantsMember 2023-05-12 0001716947 ENSC:PrefundedWarrantMember 2023-05-12 0001716947 ENSC:PrefundedWarrantMember 2023-05-11 2023-05-12 0001716947 ENSC:PrefundedWarrantMember 2023-05-11 2023-12-31 0001716947 ENSC:PrefundedWarrantMember 2023-12-31 0001716947 us-gaap:WarrantMember 2023-10-25 0001716947 us-gaap:WarrantMember 2023-11-28 0001716947 srt:MinimumMember us-gaap:WarrantMember 2023-10-25 0001716947 srt:MaximumMember us-gaap:WarrantMember 2023-10-25 0001716947 ENSC:TwentyTwentyThreeNotesMember 2023-10-23 0001716947 ENSC:TwoThousandTwentyThreeNotesMember us-gaap:SubsequentEventMember 2024-02-28 0001716947 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2024-02-28 0001716947 2022-09-30 0001716947 us-gaap:CommonStockMember ENSC:UnderwritingAgreementMember 2022-12-07 2022-12-07 0001716947 us-gaap:CommonStockMember ENSC:UnderwritingAgreementMember 2022-12-07 0001716947 us-gaap:CommonStockMember 2022-12-07 2022-12-07 0001716947 ENSC:InvestorOneMember us-gaap:CommonStockMember ENSC:UnderwritingAgreementMember 2022-12-07 0001716947 ENSC:InvestorTwoMember ENSC:PrefundedWarrantMember ENSC:UnderwritingAgreementMember 2022-12-07 0001716947 2022-12-09 2022-12-09 0001716947 2023-02-01 2023-02-02 0001716947 2023-02-02 0001716947 2023-02-06 2023-02-06 0001716947 2023-05-11 2023-05-12 0001716947 srt:MinimumMember 2023-05-12 0001716947 srt:MaximumMember 2023-05-12 0001716947 ENSC:WarrantOneMember 2023-12-31 0001716947 srt:MinimumMember ENSC:WarrantOneMember 2023-12-31 0001716947 srt:MaximumMember ENSC:WarrantOneMember 2023-12-31 0001716947 ENSC:WarrantOneMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantTwoMember 2023-12-31 0001716947 ENSC:WarrantTwoMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantThreeMember 2023-12-31 0001716947 ENSC:WarrantThreeMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantFourMember 2023-12-31 0001716947 ENSC:WarrantFourMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantFiveMember 2023-12-31 0001716947 srt:MinimumMember ENSC:WarrantFiveMember 2023-12-31 0001716947 srt:MaximumMember ENSC:WarrantFiveMember 2023-12-31 0001716947 ENSC:WarrantFiveMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantSixMember 2023-12-31 0001716947 srt:MinimumMember ENSC:WarrantSixMember 2023-12-31 0001716947 srt:MaximumMember ENSC:WarrantSixMember 2023-12-31 0001716947 ENSC:WarrantSixMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantSevenMember 2023-12-31 0001716947 srt:MinimumMember ENSC:WarrantSevenMember 2023-12-31 0001716947 srt:MaximumMember ENSC:WarrantSevenMember 2023-12-31 0001716947 ENSC:WarrantSevenMember 2023-01-01 2023-12-31 0001716947 ENSC:WarrantEightMember 2023-12-31 0001716947 ENSC:WarrantEightMember 2023-01-01 2023-12-31 0001716947 us-gaap:WarrantMember 2023-12-31 0001716947 ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001716947 srt:MinimumMember ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001716947 srt:MaximumMember ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001716947 ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001716947 ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputSharePriceMember 2021-07-02 0001716947 ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputExercisePriceMember 2021-07-02 0001716947 ENSC:LeisureAcquisitionCorpADelawareCorporationMember us-gaap:MeasurementInputExpectedTermMember 2021-07-02 0001716947 ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputPriceVolatilityMember 2021-07-02 0001716947 ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-07-02 0001716947 srt:MinimumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001716947 srt:MaximumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001716947 srt:MinimumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001716947 srt:MaximumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001716947 srt:MinimumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 srt:MaximumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 srt:MinimumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 srt:MaximumMember ENSC:ShareSubscriptionFacilityMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputSharePriceMember 2021-09-24 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExercisePriceMember 2021-09-24 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExpectedTermMember 2021-09-24 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputPriceVolatilityMember 2021-09-24 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-09-24 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputSharePriceMember 2021-11-05 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExercisePriceMember 2021-11-05 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExpectedTermMember 2021-11-05 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputPriceVolatilityMember 2021-11-05 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-11-05 0001716947 ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001716947 srt:MinimumMember ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 srt:MaximumMember ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 srt:MinimumMember ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 srt:MaximumMember ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsRemeasuredMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputSharePriceMember 2022-07-01 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExercisePriceMember 2022-07-01 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExpectedTermMember 2022-07-01 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputPriceVolatilityMember 2022-07-01 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-07-01 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputSharePriceMember 2022-08-09 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExercisePriceMember 2022-08-09 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputExpectedTermMember 2022-08-09 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputPriceVolatilityMember 2022-08-09 0001716947 ENSC:LiabilityClassifiedWarrantsGrantDateMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-08-09 0001716947 ENSC:LiabilityClassifiedWarrantsRemeasured2Member us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001716947 srt:MinimumMember ENSC:LiabilityClassifiedWarrantsRemeasured2Member us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 srt:MaximumMember ENSC:LiabilityClassifiedWarrantsRemeasured2Member us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001716947 srt:MinimumMember ENSC:LiabilityClassifiedWarrantsRemeasured2Member us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 srt:MaximumMember ENSC:LiabilityClassifiedWarrantsRemeasured2Member us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001716947 ENSC:LiabilityClassifiedWarrantsRemeasured2Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001716947 ENSC:TwoThousandTwentyOneOmnibusIncentivePlanMember 2023-12-31 0001716947 ENSC:TwoThousandTwentyOneOmnibusIncentivePlanMember 2022-01-31 0001716947 ENSC:TwoThousandTwentyOneOmnibusIncentivePlanMember 2023-02-28 0001716947 ENSC:TwoThousandTwentyOneOmnibusIncentivePlanMember 2023-08-31 0001716947 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-12-31 0001716947 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001716947 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001716947 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001716947 ENSC:BoardOfMembersMember 2023-01-01 2023-12-31 0001716947 ENSC:BoardOfMembersMember 2022-01-01 2022-12-31 0001716947 srt:MinimumMember 2022-01-01 2022-12-31 0001716947 srt:MaximumMember 2022-01-01 2022-12-31 0001716947 srt:MinimumMember 2022-12-31 0001716947 srt:MaximumMember 2022-12-31 0001716947 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001716947 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001716947 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001716947 us-gaap:EmployeeStockOptionMember 2023-12-31 0001716947 us-gaap:EmployeeStockOptionMember ENSC:StockOptionAvailableForFutureGrantUnder2021OmnibusIncentivePlanMember 2023-12-31 0001716947 ENSC:WarrantOutstandingMember 2023-12-31 0001716947 ENSC:EnsysceBiosciencesIncMember 2023-01-01 2023-12-31 0001716947 country:US 2023-01-01 2023-12-31 0001716947 country:US 2022-01-01 2022-12-31 0001716947 us-gaap:DomesticCountryMember 2023-12-31 0001716947 us-gaap:CaliforniaFranchiseTaxBoardMember 2022-12-31 0001716947 us-gaap:DomesticCountryMember 2018-12-31 0001716947 us-gaap:DomesticCountryMember 2017-12-31 0001716947 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2023-12-31 0001716947 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2023-12-31 0001716947 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001716947 ENSC:ChiefExecutiveOfficerAndBoardMemberMember 2022-07-01 2022-07-31 0001716947 2022-10-01 2022-10-31 0001716947 us-gaap:WarrantMember 2023-10-23 0001716947 us-gaap:SubsequentEventMember 2024-01-31 2024-01-31 0001716947 ENSC:TwoThousandTwentyThreeNotesMember us-gaap:SubsequentEventMember 2024-01-31 2024-01-31 0001716947 ENSC:TwoThousandTwentyThreeNotesMember us-gaap:SubsequentEventMember 2024-01-31 2024-02-01 0001716947 us-gaap:SubsequentEventMember 2024-02-28 0001716947 srt:MinimumMember us-gaap:SubsequentEventMember 2024-02-28 0001716947 srt:MaximumMember us-gaap:SubsequentEventMember 2024-02-28 0001716947 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-02-28 iso4217:USD shares iso4217:USD shares pure ENSC:Tradingdays true 0001716947 S-1/A P5Y P3Y P0Y Amendment No. 1 ENSYSCE BIOSCIENCES, INC. DE 82-2755287 7946 Ivanhoe Avenue Suite 201 La Jolla CA 92037 (858) 263-4196 7946 Ivanhoe Avenue Suite 201 La Jolla CA 92037 858 263-4196 Non-accelerated Filer true false 1123604 3147702 97561 276821 27165 1067703 1847481 2288868 5299169 419217 585883 2708085 5885052 1936007 2943791 542260 2226494 27315 854697 4266610 3332964 9464210 140148 26388 310346 26388 450494 3359352 9914704 0.0001 0.0001 1500000 1500000 0 0 0 0 0.0001 0.0001 250000000 250000000 3146157 534571 3146076 534490 315 53 121233901 107216566 -121557074 -110931063 -322858 -3714444 -328409 -315208 -651267 -4029652 2708085 5885052 2230520 2523383 7587473 19835875 5361234 6909603 12948707 26745478 -10718187 -24222095 -3609944 1137740 -146479 -1792154 3737371 283958 6730613 353945 109525 15420 86223 91912 14410 -10626275 -24207685 -13201 -35393 12937 913204 -10626011 -25085496 -4.69 -4.69 -139.42 -139.42 2264060 2264060 179925 179925 102678 10 77967314 -85845567 -279815 -8158058 208 54250 54250 3278 181999 18 21485886 21485904 3838 1 191617 191618 608382 608382 241666 24 3783216 3783240 2760074 2760074 -547377 -547377 823 913204 -913204 -24172292 -35393 -24207685 534490 53 107216566 -110931063 -315208 -4029652 534490 53 107216566 -110931063 -315208 -4029652 60938 6 -6 44444 4 399996 400000 408580 41 3056851 3056892 1381619 139 9049865 9050004 879160 879160 1066483 1066483 -447879 -447879 716867 72 -72 -862 12937 -12937 -10613074 -13201 -10626275 3146076 315 121233901 -121557074 -328409 -651267 3146076 315 121233901 -121557074 -328409 -651267 -10626275 -24207685 4500 18648 60488 326151 -146479 -1792154 -3609944 946085 3737371 283958 6730613 879160 1071843 -150 -3 60035 -179260 -164900 -1392181 -1652756 -1234287 2642686 -1284233 1021478 -10779982 -17887439 4500 4500 9050004 3783240 1605635 7533915 1000208 1408364 447879 547377 451668 595509 8755884 8765905 -2024098 -9117034 3147702 12264736 1123604 3147702 3200 1600 1742481 3056892 17521271 191618 608382 136000 1066483 226503 445737 399949 400000 12937 913204 <p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zih1NQdGP9Mi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_825_zer531MhFIEb">ORGANIZATION AND PRINCIPAL ACTIVITIES</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensysce Biosciences, Inc. (“Ensysce”), along with its <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EBIRIncMember_zKGVnD1opCa4" title="Ownership percentage">79.2</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%-owned subsidiary, EBIR, Inc. (“EBIR”, formerly known as Covistat, Inc.) and its wholly-owned subsidiaries EBI Operating, Inc. and EBI OpCo, Inc. (collectively, the “Company”), is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The primary focus of the Company is its program developing abuse and overdose resistant pain technology with a clinical stage program being the abuse resistant, TAAP (Trypsin Activated Abuse Protection) opioid product candidate, PF614. In addition, the Company is developing its MPAR® (Multi-Pill Abuse Resistant) technology for overdose protection which will be applied to the PF614 program. The Company is also applying its TAAP and MPAR® technology to a methadone prodrug for use in the treatment of Opioid Use Disorder.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2020, the Company commenced an initiative to develop a therapeutic for the treatment of certain coronavirus infections through the formation of a separate entity, EBIR, a Delaware corporation. Pursuant to the articles of incorporation, EBIR was authorized to issue <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20201231__us-gaap--BusinessAcquisitionAxis__custom--EBIRIncMember_zPnAXafSAahc" title="Common stock, shares authorized">1,000,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pp3d_c20201231__us-gaap--BusinessAcquisitionAxis__custom--EBIRIncMember_zgEnIr44qUu4" title="Common stock, par value">0.001 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value per share, and <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20201231__us-gaap--BusinessAcquisitionAxis__custom--EBIRIncMember_zf5ShxnfVms1" title="Preferred stock, shares authorized">100,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pp3d_c20201231__us-gaap--BusinessAcquisitionAxis__custom--EBIRIncMember_zXLAWxXX5a4b" title="Preferred stock, par value">0.001 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value per share. Ensysce is a <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EBIRIncMember_ztHr7uOT00l" title="Ownership percentage">79.2</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% stockholder in EBIR, with <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--TitleOfIndividualAxis__custom--KeyPersonnelMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EBIRIncMember_zHn3JgxcGYKh" title="Ownership percentage">19.8</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--TitleOfIndividualAxis__custom--UnrelatedPartyMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EBIRIncMember_zezO8K1WhLU4" title="Ownership percentage">1.0</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the shares held by certain key personnel of the Company and an unrelated party, respectively. The non-Ensysce owned shares and the activity are reflected on the financial statements as noncontrolling interests.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently operates in one business segment, which is pharmaceuticals. The Company is not organized by market and is managed and operated as one business. A single management team reports to the chief operating decision maker, the Chief Executive Officer.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> 0.792 1000000 0.001 100000 0.001 0.792 0.198 0.010 <p id="xdx_803_eus-gaap--BasisOfAccounting_z1uLbGFSiOPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_82B_z3Bz0hcbXKv3">BASIS OF PRESENTATION</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities Exchange Commission (“SEC”). The consolidated financial statements include the accounts of Ensysce Biosciences, Inc. and its subsidiaries. All intercompany balances and transactions have been eliminated in the consolidation.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the Company completed a <span id="xdx_909_eus-gaap--StockholdersEquityReverseStockSplit_c20230301__20230331_zy9U6hOC61b8" title="Reverse stock split">1-for-12 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reverse split of its outstanding common stock. All references in these consolidated financial statements to shares and per share amounts in all periods have been retroactively restated to reflect the split. The number of authorized shares and the par value of the shares did not change as a result of the reverse stock split.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not generated any product revenue. There is no assurance that profitable operations will ever be achieved, and, if achieved, would be sustained on a continuing basis. Product development activities, clinical and pre-clinical testing, and commercialization of the Company’s product candidates are necessary to develop the Company’s products and will require significant additional financing. There can be no assurance the Company will be able to obtain such funds. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company believes in the viability of its strategy to ultimately realize revenues and in its ability to raise additional funds, management cannot be certain that additional funding will be available on acceptable terms, or at all. The Company’s ability to continue as a going concern is dependent upon its ability to obtain adequate financing and achieve profitable operations. As a result, these plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months following the date these consolidated financial statements were issued.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> 1-for-12 <p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zkTqaHOrGX11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 - <span id="xdx_829_zHiwiCBsibpl">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_zDivFpYfZqV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_863_zcmibkv7XCU6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates and Assumptions</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosed in the accompanying notes. Actual results may differ from those estimates and such differences may be material to the consolidated financial statements. The more significant estimates and assumptions by management include, but are not limited to, the expense recognition for certain accrued research and development services.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zcDSk3TLeBCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_865_zKM4e5rt87Dg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash and Cash Equivalents</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the consolidated balance sheets and consolidated statements of cash flows, the Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zkuVBPb9auwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11pt; text-align: justify; text-indent: -11pt"><span style="-sec-ix-redline: true"><span id="xdx_861_zTnNiFMryQyf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentrations of Credit Risk and Off-Balance Sheet Risk</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are financial instruments that are potentially subject to concentrations of credit risk. The Company’s cash and cash equivalents are deposited in accounts at large financial institutions and amounts currently exceed federally insured limits. The Company has no financial instruments with off-balance sheet risk of loss. Additionally, the Company had a concentration in accounts payable, as <span id="xdx_90E_eus-gaap--ConcentrationRiskBenchmarkDescription_c20230101__20231231_zdIRmq4X0xpd" title="Concentration risk benchmark description">two research and development vendors made up greater than 10% individually, and 38% and 65% in aggregate</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, of the outstanding accounts payable balance as of December 31, 2023 and 2022, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zcmfI64ud8kl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_866_zMhM6hYhDeKe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Property and Equipment</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment include office and laboratory equipment that is recorded at cost and depreciated using the straight-line method over the estimated useful lives of <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231__srt--RangeAxis__srt--MinimumMember_zK59WW9iX0R4" title="Property and equipment estimated useful lives::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0600">five </span></span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__srt--RangeAxis__srt--MaximumMember_z2FhB0ZgNtPf" title="Property and equipment estimated useful lives">six years</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Property and equipment are fully depreciated as such there is <span id="xdx_902_eus-gaap--Depreciation_pn6n6_do_c20230101__20231231_zkDP1VpbwRt" title="Depreciation"><span id="xdx_907_eus-gaap--Depreciation_pn6n6_do_c20220101__20221231_zHaoUE5yQ2lh" title="Depreciation">no</span></span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">depreciation recognized in the years ended December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zCoA8EaB3svi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in; text-align: justify; text-indent: -0.15in"><span style="-sec-ix-redline: true"><span id="xdx_860_zFk7RMyK8Ka4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair Value Measurement</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 820, <i>Fair Value Measurements</i>, (“ASC 820”) provides guidance on the development and disclosure of fair value measurements. Under this accounting guidance, fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between willing market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting guidance classifies fair value measurements in one of the following three categories for disclosure purposes:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices in active markets for identical assets or liabilities.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level at which to classify them for each reporting period. This determination requires significant judgments to be made by the Company.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the recorded values of cash and cash equivalents, prepaid expenses, accounts payable, and accrued expenses and other liabilities approximate their fair values due to the short-term nature of these items.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021 Notes</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 the Company issued convertible notes with a face value of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20210101__20211231_z5ugu9wUqd5l" title="Proceeds from issuance of debt">15.9 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The Company elected the fair value option to account for the convertible notes as it believes the fair value option provides users of the financial statements with greater ability to estimate the outcome of future events as facts and circumstances change, particularly with respect to changes in the fair value of the common stock underlying the conversion option and redemption feature. The fair value estimate of the 2021 Notes was based on a discounted cash flow model and a Monte Carlo simulation, which represent Level 3 measurements. Significant assumptions include the discount rate used in the discounted cash flow model and the expected premium for conversion and expected volatility used in the Monte Carlo simulation. Changes in the fair value of the notes are recognized in other income (expense) for each reporting period. Refer to Note 7 for details of the terms and conditions of the 2021 Notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022 Notes</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2022 the Company issued convertible notes with a face value of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20220701__20220731_zwbUqrmSqwwb" title="Proceeds from issuance of debt">8.5 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The 2022 Notes are accounted for under ASC 480 – <i>Distinguishing Liabilities from Equity, </i>due to share settlement features contained within the notes. As a result, the 2022 Notes are recorded as liabilities at fair value at the balance sheet date with changes in the fair value of the notes recognized in other income (expense) for each reporting period. The fair value estimate of the 2022 Notes was based on a discounted cash flow model and a Monte Carlo simulation, which represent Level 3 measurements. Significant assumptions include the discount rate used in the discounted cash flow model and the expected premium for conversion and expected volatility used in the Monte Carlo simulation. Refer to Note 7 for details of the terms and conditions of the 2022 Notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 the Company issued liability classified warrants in connection with the issuance of the 2021 Notes. In 2022 the Company issued liability classified warrants in connection with the issuance of the 2022 Notes. The warrants were liability classified due to certain cash settlement features and included in “Other long-term liabilities” on the consolidated balance sheets. The Company uses a Black Scholes model to estimate the fair value of the warrants. Changes in the fair value of the warrants are recognized in other income (expense) for each reporting period. Refer to Note 8 for additional details of the warrants.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_897_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zTmNlADG6fmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present assets and liabilities measured and recorded at fair value on the Company’s consolidated balance sheet as of December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B3_zZyu7z2ALpF4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49E_20231231_zxbfQvOt94Q9" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqGYc94XiTJ9" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPHPhZuKhpBi" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1hU4AG8tEuf" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pp0p0_zAonbPjg2n81" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Fair value of convertible note</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pp0p0_zeNhHp57O1T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Liability classified warrants<br/></span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_zv2JRPI81t0k" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_490_20221231_zdCXbOcBkMQj" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoCBfn8dPAYe" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhOOBQ8TNpv5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49B_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqdWY3AxyFSb" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pp0p0_zUsQScUDuLfe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Fair value of convertible note</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pp0p0_zbwFzcgs7Lbb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Liability classified warrants</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">310,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0638">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">310,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_z4ISR0s63lbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0643">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A1_zrtqk9bk2Z83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_892_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zafMDk6SpPrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the change in fair value of the Company’s Level 3 assets and liabilities for the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_zEfMk7QjzKwi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF CHANGE IN FAIR VALUE OF COMPANY’S LEVEL 3</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">For the year ended December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Convertible note</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Liability classified warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Fair value, December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231_zsTi2tlBQKR7" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zewSybzCAsVl" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zx2RJtfpCPOb" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">310,346</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Conversions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pp0p0_c20230101__20231231_z75f7eOS1MC1" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true">(3,056,892</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zQtlgBGpWC55" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true">(3,056,892</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zl0IIrJNAOe1" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0658">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Cash payments</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pp0p0_c20230101__20231231_zvzznORMnkUb" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true">(415,351</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zdphX1IHcam" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true">(415,351</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zKUlsSg5hawe" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Cash true up liability</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pp0p0_c20230101__20231231_zubUwcqUCfkc" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true">(584,857</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zL3kPCtpH3P" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true">(584,857</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_ziweHIygQkO7" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231_zVLC9K3quGa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(430,437</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zx8fE3DKmXF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(146,479</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zCdBontZneH5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(283,958</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Fair value, December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231_zDPdGdn6P3D5" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zkEkNJmTBCl7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zhByIrzTdGG1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AE_zZdgRlHut0ed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Federal Grants</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2018, the National Institutes of Health (“NIH”) through the National Institute on Drug Abuse awarded the Company a research and development grant related to the development of its MPAR® overdose prevention technology (the “MPAR Grant”). The total approved budget for the initial two-year period was approximately $<span id="xdx_90B_eus-gaap--GrantsReceivable_iI_pn5n6_c20180930_zXzueGLycwne" title="Grants receivable">5.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million ($<span id="xdx_900_eus-gaap--GrantsReceivable_iI_pn5n6_c20180930__srt--StatementScenarioAxis__custom--YearOneMember_zdPAWPnwyka1" title="Grants receivable">3.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_906_eus-gaap--GrantsReceivable_iI_pn5n6_c20180930__srt--StatementScenarioAxis__custom--YearTwoMember_zhC9FkaFjmx4" title="Grants receivable">2.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in years 1 and 2 respectively) of which the Company would contribute $<span id="xdx_906_ecustom--ContributionOfGrants_iI_pn5n6_c20180930__srt--StatementScenarioAxis__custom--YearOneMember_zArIf65Qn6A4" title="Contribution of grants">1.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in the first year of the grant. In August 2019, the grant was amended such that the approved budget for the two-year period decreased to approximately $<span id="xdx_903_eus-gaap--GrantsReceivable_iI_pn5n6_c20190831_z9bF5SNZhTgj" title="Grants receivable">5.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million ($<span id="xdx_90B_eus-gaap--GrantsReceivable_iI_pn5n6_c20190831__srt--StatementScenarioAxis__custom--YearOneMember_z5cxWK9BPNjb" title="Grants receivable">2.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_907_eus-gaap--GrantsReceivable_iI_pn5n6_c20190831__srt--StatementScenarioAxis__custom--YearTwoMember_zo0HN3kof5Ta" title="Grants receivable">3.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in years 1 and 2, respectively). In June 2021, the Company received a Notice of Award for an additional $<span id="xdx_90D_eus-gaap--GrantsReceivable_iI_pn5n6_c20210630__srt--StatementScenarioAxis__custom--YearThreeMember_zI4KDtznuijd" title="Grants receivable">2.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of funding in year 3 under the MPAR Grant beginning July 1, 2021. In June 2022, the Company received a Notice of Award for an additional $<span id="xdx_904_eus-gaap--GrantsReceivable_iI_pn5n6_c20220630__srt--StatementScenarioAxis__custom--YearFourMember_z3hNHpNJjy4d" title="Grants receivable">2.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of funding in year 4 under the MPAR Grant from July 1, 2022 through June 30, 2023. This brings total funding under this grant to approximately $<span id="xdx_90D_eus-gaap--GrantsReceivable_iI_pn5n6_c20220630_zet7kHBtBwy2" title="Grants receivable">10.7 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2019, the NIH/National Institute on Drug Abuse awarded the Company a second research and development grant related to the development of its TAAP/MPAR® abuse deterrent technology for Opioid Use Disorder (the “OUD Grant”). The total approved budget for the grant was approximately $<span id="xdx_909_eus-gaap--GrantsReceivable_iI_pn5n6_c20190930_zXskFGE0agp1" title="Grants receivable">5.4</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, and the current grant period ends in August of 2024. As of December 31, 2023, the remaining funding under the grant is $<span id="xdx_908_eus-gaap--GrantsReceivable_iI_pn5n6_c20231231_zm51mqQxciQ3" title="Grants receivable">2.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue when costs related to the grants are incurred and assessed as reimbursable. The Company believes this policy is consistent with the overarching premise in Accounting Standards Codification Topic 606, <i>Revenue from Contracts with </i>Customers (“ASC 606”), applied by analogy, to ensure that it recognizes revenues to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services, even though there is no “exchange” as defined in ASC 606. The Company believes the recognition of revenue as costs are incurred and reimbursable amounts become due is analogous to the concept of transfer of control of a service over time under ASC 606.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89D_ecustom--ScheduleOfRevenueRecognitionUnderGrantsTableTextBlock_z2gBqfw9hC59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revenue recognized under the MPAR Grant and OUD Grant was as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span id="xdx_8B1_zjIiEDnrPYi8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REVENUE RECOGNIZATION UNDER GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231_z1VsiRJHVzf8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zihbY1zo3rC7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MPARMember_z8hKJi5tl3Z2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="-sec-ix-redline: true">MPAR</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,293,238</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">2,006,885</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TAAPOUDMember_zDxWLwQ86uAf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">TAAP/OUD</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">937,282</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">516,498</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_z5ReJrEcD379" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,230,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,523,383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AC_zyhEewL8ck0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts requested or eligible to be requested through the NIH payment management system, but for which cash has not been received, are presented as an unbilled receivable on the Company’s consolidated balance sheet. As all amounts are expected to be remitted timely, no valuation allowances are recorded.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zjxvgdSu9t2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86B_zj7NeFf32QC6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research and Development Costs</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s research and development expenses consist primarily of third-party research and development expenses, consulting expenses, animal and clinical studies, and any allocable direct overhead, including facilities and depreciation costs, as well as salaries, payroll taxes, and employee benefits for those individuals directly involved in ongoing research and development efforts. Research and development expenses are charged to expense as incurred. Payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_849_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_za3Hl2QNiycb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_868_zMYsaywsk0B7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General and Administrative Expenses</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses consist primarily of personnel costs associated with the Company’s executive, finance, human resources, compliance, and other administrative personnel, as well as accounting and legal professional services fees.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJrxNq5aQDdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86E_zDAAeb5rTcCc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based Compensation</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses stock-based compensation over the requisite service period based on the estimated grant-date fair value of the awards using a graded amortization approach. The Company accounts for forfeitures as they occur.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. Stock-based compensation costs are recorded in research and development and general and administrative expenses in the consolidated statements of operations.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time-to-time equity classified awards may be modified. On the modification date, the Company estimates the fair value of the awards immediately before and immediately after modification. The incremental increase in fair value is recognized as expense immediately to the extent the underlying equity awards are vested and on a straight-line basis over the same remaining amortization schedule as the unvested underlying equity awards.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zLZV829S4P9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_867_zjZJzLVhm1Sk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income Taxes</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are recorded in accordance with ASC 740, <i>Income Taxes</i> (“ASC 740”), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that the benefit would more likely than not be realized assuming examination by the taxing authority. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as consideration of the available facts and circumstances. The Company recognizes any interest and penalties accrued related to unrecognized tax benefits as income tax expense.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zAEsmjUpqvIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_863_z2OHW4aKKij3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earnings per Share</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basic earnings per share is calculated by dividing the Company’s net income or loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. The diluted earnings per share is calculated by dividing the Company’s net earnings attributable to common stockholders by the diluted weighted average number of common shares outstanding during the period, determined using the treasury stock method and the average stock price during the period.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z0O50at2iEtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted average shares have been excluded from the calculations of diluted weighted average common shares outstanding because they would have been anti-dilutive (the Company has utilized the principal balance outstanding and the end of period conversion price for the Convertible Notes for the purposes of the weighted average share calculation below):</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zHJxsQHl9Njh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF WEIGHTED AVERAGE SHARES OF ANTI-DILUTIVE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_zsW02oHUl7jd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zP9SWZK01P3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zoezbNkhvHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Stock options</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">131,767</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,302</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zYNcrrBMScpf" style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">RSUs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0734">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,772</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zb1dqpvHrTNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Warrants</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,798,114</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">138,485</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zRGLfY0uv0Ec" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Convertible Notes</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">1,171,292</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">73,326</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zawwYHI5bfge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">5,101,173</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">241,885</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z0fBAPVFRvR8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Anti-dilutive weighted average shares</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">5,101,173</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">241,885</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AF_zSgY8SqW1zDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_840_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zBfJQDy2DZle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86D_zjQTplf5zXIi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently Adopted Accounting Pronouncements</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Topic 470) to address issues identified as a result of the complexity with applying GAAP for certain financial instruments with characteristics of liabilities and equity. The FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock, resulting in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Certain types of convertible instruments will continue to be subject to separation models: (a) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (b) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. For convertible instruments, the contracts primarily affected are those with beneficial conversions or cash conversion features as the accounting models for those specific features have been removed. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives due to a failure to meet the settlement conditions of the derivatives scope exceptions. The FASB simplified the settlement assessment by removing the requirements to (a) consider whether the contract would be settled in registered shares, (b) to consider whether collateral is required to be posted, and (c) assess shareholder rights. The FASB also decided to enhance information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted the standard with an effective date of January 1, 2023 and the adoption did not have a significant impact on the consolidated financial statements.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwFuRB82PnY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_865_zXUQ40R30Pd1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently Issued Accounting Pronouncements</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which sets forth improvements to the current segment disclosure requirements in accordance with Topic 280 “Segment Reporting,” including clarifying that entities with a single reportable segment are subject to both new and existing segment reporting requirements. ASU 2023-07 will be effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. Adoption of this ASU is currently being evaluated by the Company.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. ASU 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></span></p> <p id="xdx_859_zZ5sMPJlfzKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_zDivFpYfZqV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_863_zcmibkv7XCU6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates and Assumptions</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and disclosed in the accompanying notes. Actual results may differ from those estimates and such differences may be material to the consolidated financial statements. The more significant estimates and assumptions by management include, but are not limited to, the expense recognition for certain accrued research and development services.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zcDSk3TLeBCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_865_zKM4e5rt87Dg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash and Cash Equivalents</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the consolidated balance sheets and consolidated statements of cash flows, the Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zkuVBPb9auwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 11pt; text-align: justify; text-indent: -11pt"><span style="-sec-ix-redline: true"><span id="xdx_861_zTnNiFMryQyf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentrations of Credit Risk and Off-Balance Sheet Risk</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents are financial instruments that are potentially subject to concentrations of credit risk. The Company’s cash and cash equivalents are deposited in accounts at large financial institutions and amounts currently exceed federally insured limits. The Company has no financial instruments with off-balance sheet risk of loss. Additionally, the Company had a concentration in accounts payable, as <span id="xdx_90E_eus-gaap--ConcentrationRiskBenchmarkDescription_c20230101__20231231_zdIRmq4X0xpd" title="Concentration risk benchmark description">two research and development vendors made up greater than 10% individually, and 38% and 65% in aggregate</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, of the outstanding accounts payable balance as of December 31, 2023 and 2022, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> two research and development vendors made up greater than 10% individually, and 38% and 65% in aggregate <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zcmfI64ud8kl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_866_zMhM6hYhDeKe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Property and Equipment</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment include office and laboratory equipment that is recorded at cost and depreciated using the straight-line method over the estimated useful lives of <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231__srt--RangeAxis__srt--MinimumMember_zK59WW9iX0R4" title="Property and equipment estimated useful lives::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0600">five </span></span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__srt--RangeAxis__srt--MaximumMember_z2FhB0ZgNtPf" title="Property and equipment estimated useful lives">six years</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Property and equipment are fully depreciated as such there is <span id="xdx_902_eus-gaap--Depreciation_pn6n6_do_c20230101__20231231_zkDP1VpbwRt" title="Depreciation"><span id="xdx_907_eus-gaap--Depreciation_pn6n6_do_c20220101__20221231_zHaoUE5yQ2lh" title="Depreciation">no</span></span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">depreciation recognized in the years ended December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> P6Y 0 0 <p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zCoA8EaB3svi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.15in; text-align: justify; text-indent: -0.15in"><span style="-sec-ix-redline: true"><span id="xdx_860_zFk7RMyK8Ka4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair Value Measurement</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 820, <i>Fair Value Measurements</i>, (“ASC 820”) provides guidance on the development and disclosure of fair value measurements. Under this accounting guidance, fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between willing market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting guidance classifies fair value measurements in one of the following three categories for disclosure purposes:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices in active markets for identical assets or liabilities.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level at which to classify them for each reporting period. This determination requires significant judgments to be made by the Company.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the recorded values of cash and cash equivalents, prepaid expenses, accounts payable, and accrued expenses and other liabilities approximate their fair values due to the short-term nature of these items.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021 Notes</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 the Company issued convertible notes with a face value of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20210101__20211231_z5ugu9wUqd5l" title="Proceeds from issuance of debt">15.9 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The Company elected the fair value option to account for the convertible notes as it believes the fair value option provides users of the financial statements with greater ability to estimate the outcome of future events as facts and circumstances change, particularly with respect to changes in the fair value of the common stock underlying the conversion option and redemption feature. The fair value estimate of the 2021 Notes was based on a discounted cash flow model and a Monte Carlo simulation, which represent Level 3 measurements. Significant assumptions include the discount rate used in the discounted cash flow model and the expected premium for conversion and expected volatility used in the Monte Carlo simulation. Changes in the fair value of the notes are recognized in other income (expense) for each reporting period. Refer to Note 7 for details of the terms and conditions of the 2021 Notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022 Notes</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2022 the Company issued convertible notes with a face value of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20220701__20220731_zwbUqrmSqwwb" title="Proceeds from issuance of debt">8.5 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The 2022 Notes are accounted for under ASC 480 – <i>Distinguishing Liabilities from Equity, </i>due to share settlement features contained within the notes. As a result, the 2022 Notes are recorded as liabilities at fair value at the balance sheet date with changes in the fair value of the notes recognized in other income (expense) for each reporting period. The fair value estimate of the 2022 Notes was based on a discounted cash flow model and a Monte Carlo simulation, which represent Level 3 measurements. Significant assumptions include the discount rate used in the discounted cash flow model and the expected premium for conversion and expected volatility used in the Monte Carlo simulation. Refer to Note 7 for details of the terms and conditions of the 2022 Notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 the Company issued liability classified warrants in connection with the issuance of the 2021 Notes. In 2022 the Company issued liability classified warrants in connection with the issuance of the 2022 Notes. The warrants were liability classified due to certain cash settlement features and included in “Other long-term liabilities” on the consolidated balance sheets. The Company uses a Black Scholes model to estimate the fair value of the warrants. Changes in the fair value of the warrants are recognized in other income (expense) for each reporting period. Refer to Note 8 for additional details of the warrants.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_897_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zTmNlADG6fmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present assets and liabilities measured and recorded at fair value on the Company’s consolidated balance sheet as of December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B3_zZyu7z2ALpF4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49E_20231231_zxbfQvOt94Q9" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqGYc94XiTJ9" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPHPhZuKhpBi" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1hU4AG8tEuf" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pp0p0_zAonbPjg2n81" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Fair value of convertible note</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pp0p0_zeNhHp57O1T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Liability classified warrants<br/></span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_zv2JRPI81t0k" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_490_20221231_zdCXbOcBkMQj" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoCBfn8dPAYe" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhOOBQ8TNpv5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49B_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqdWY3AxyFSb" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pp0p0_zUsQScUDuLfe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Fair value of convertible note</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pp0p0_zbwFzcgs7Lbb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Liability classified warrants</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">310,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0638">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">310,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_z4ISR0s63lbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0643">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A1_zrtqk9bk2Z83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_892_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zafMDk6SpPrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the change in fair value of the Company’s Level 3 assets and liabilities for the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_zEfMk7QjzKwi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF CHANGE IN FAIR VALUE OF COMPANY’S LEVEL 3</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">For the year ended December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Convertible note</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Liability classified warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Fair value, December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231_zsTi2tlBQKR7" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zewSybzCAsVl" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zx2RJtfpCPOb" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">310,346</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Conversions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pp0p0_c20230101__20231231_z75f7eOS1MC1" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true">(3,056,892</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zQtlgBGpWC55" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true">(3,056,892</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zl0IIrJNAOe1" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0658">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Cash payments</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pp0p0_c20230101__20231231_zvzznORMnkUb" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true">(415,351</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zdphX1IHcam" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true">(415,351</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zKUlsSg5hawe" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Cash true up liability</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pp0p0_c20230101__20231231_zubUwcqUCfkc" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true">(584,857</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zL3kPCtpH3P" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true">(584,857</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_ziweHIygQkO7" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231_zVLC9K3quGa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(430,437</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zx8fE3DKmXF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(146,479</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zCdBontZneH5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(283,958</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Fair value, December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231_zDPdGdn6P3D5" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zkEkNJmTBCl7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zhByIrzTdGG1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AE_zZdgRlHut0ed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Federal Grants</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2018, the National Institutes of Health (“NIH”) through the National Institute on Drug Abuse awarded the Company a research and development grant related to the development of its MPAR® overdose prevention technology (the “MPAR Grant”). The total approved budget for the initial two-year period was approximately $<span id="xdx_90B_eus-gaap--GrantsReceivable_iI_pn5n6_c20180930_zXzueGLycwne" title="Grants receivable">5.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million ($<span id="xdx_900_eus-gaap--GrantsReceivable_iI_pn5n6_c20180930__srt--StatementScenarioAxis__custom--YearOneMember_zdPAWPnwyka1" title="Grants receivable">3.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_906_eus-gaap--GrantsReceivable_iI_pn5n6_c20180930__srt--StatementScenarioAxis__custom--YearTwoMember_zhC9FkaFjmx4" title="Grants receivable">2.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in years 1 and 2 respectively) of which the Company would contribute $<span id="xdx_906_ecustom--ContributionOfGrants_iI_pn5n6_c20180930__srt--StatementScenarioAxis__custom--YearOneMember_zArIf65Qn6A4" title="Contribution of grants">1.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in the first year of the grant. In August 2019, the grant was amended such that the approved budget for the two-year period decreased to approximately $<span id="xdx_903_eus-gaap--GrantsReceivable_iI_pn5n6_c20190831_z9bF5SNZhTgj" title="Grants receivable">5.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million ($<span id="xdx_90B_eus-gaap--GrantsReceivable_iI_pn5n6_c20190831__srt--StatementScenarioAxis__custom--YearOneMember_z5cxWK9BPNjb" title="Grants receivable">2.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_907_eus-gaap--GrantsReceivable_iI_pn5n6_c20190831__srt--StatementScenarioAxis__custom--YearTwoMember_zo0HN3kof5Ta" title="Grants receivable">3.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in years 1 and 2, respectively). In June 2021, the Company received a Notice of Award for an additional $<span id="xdx_90D_eus-gaap--GrantsReceivable_iI_pn5n6_c20210630__srt--StatementScenarioAxis__custom--YearThreeMember_zI4KDtznuijd" title="Grants receivable">2.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of funding in year 3 under the MPAR Grant beginning July 1, 2021. In June 2022, the Company received a Notice of Award for an additional $<span id="xdx_904_eus-gaap--GrantsReceivable_iI_pn5n6_c20220630__srt--StatementScenarioAxis__custom--YearFourMember_z3hNHpNJjy4d" title="Grants receivable">2.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of funding in year 4 under the MPAR Grant from July 1, 2022 through June 30, 2023. This brings total funding under this grant to approximately $<span id="xdx_90D_eus-gaap--GrantsReceivable_iI_pn5n6_c20220630_zet7kHBtBwy2" title="Grants receivable">10.7 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2019, the NIH/National Institute on Drug Abuse awarded the Company a second research and development grant related to the development of its TAAP/MPAR® abuse deterrent technology for Opioid Use Disorder (the “OUD Grant”). The total approved budget for the grant was approximately $<span id="xdx_909_eus-gaap--GrantsReceivable_iI_pn5n6_c20190930_zXskFGE0agp1" title="Grants receivable">5.4</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, and the current grant period ends in August of 2024. As of December 31, 2023, the remaining funding under the grant is $<span id="xdx_908_eus-gaap--GrantsReceivable_iI_pn5n6_c20231231_zm51mqQxciQ3" title="Grants receivable">2.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue when costs related to the grants are incurred and assessed as reimbursable. The Company believes this policy is consistent with the overarching premise in Accounting Standards Codification Topic 606, <i>Revenue from Contracts with </i>Customers (“ASC 606”), applied by analogy, to ensure that it recognizes revenues to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services, even though there is no “exchange” as defined in ASC 606. The Company believes the recognition of revenue as costs are incurred and reimbursable amounts become due is analogous to the concept of transfer of control of a service over time under ASC 606.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89D_ecustom--ScheduleOfRevenueRecognitionUnderGrantsTableTextBlock_z2gBqfw9hC59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revenue recognized under the MPAR Grant and OUD Grant was as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span id="xdx_8B1_zjIiEDnrPYi8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REVENUE RECOGNIZATION UNDER GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231_z1VsiRJHVzf8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zihbY1zo3rC7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MPARMember_z8hKJi5tl3Z2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="-sec-ix-redline: true">MPAR</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,293,238</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">2,006,885</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TAAPOUDMember_zDxWLwQ86uAf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">TAAP/OUD</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">937,282</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">516,498</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_z5ReJrEcD379" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,230,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,523,383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AC_zyhEewL8ck0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts requested or eligible to be requested through the NIH payment management system, but for which cash has not been received, are presented as an unbilled receivable on the Company’s consolidated balance sheet. As all amounts are expected to be remitted timely, no valuation allowances are recorded.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> 15900000 8500000 <p id="xdx_897_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zTmNlADG6fmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables present assets and liabilities measured and recorded at fair value on the Company’s consolidated balance sheet as of December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B3_zZyu7z2ALpF4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49E_20231231_zxbfQvOt94Q9" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zqGYc94XiTJ9" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zPHPhZuKhpBi" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1hU4AG8tEuf" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pp0p0_zAonbPjg2n81" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Fair value of convertible note</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pp0p0_zeNhHp57O1T5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Liability classified warrants<br/></span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_zv2JRPI81t0k" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_490_20221231_zdCXbOcBkMQj" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_492_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoCBfn8dPAYe" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhOOBQ8TNpv5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49B_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqdWY3AxyFSb" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 1</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 2</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Level 3</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pp0p0_zUsQScUDuLfe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Fair value of convertible note</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pp0p0_zbwFzcgs7Lbb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Liability classified warrants</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">310,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0638">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">310,346</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--FairValueNetAssetLiability_iI_pp0p0_z4ISR0s63lbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0643">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 26388 26388 26388 26388 4203579 4203579 310346 310346 4513925 4513925 <p id="xdx_892_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zafMDk6SpPrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the change in fair value of the Company’s Level 3 assets and liabilities for the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_zEfMk7QjzKwi" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF CHANGE IN FAIR VALUE OF COMPANY’S LEVEL 3</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">For the year ended December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Convertible note</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Liability classified warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Fair value, December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231_zsTi2tlBQKR7" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">4,513,925</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zewSybzCAsVl" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zx2RJtfpCPOb" style="width: 16%; text-align: right" title="Beginning balance"><span style="-sec-ix-redline: true">310,346</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Conversions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pp0p0_c20230101__20231231_z75f7eOS1MC1" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true">(3,056,892</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zQtlgBGpWC55" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true">(3,056,892</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zl0IIrJNAOe1" style="text-align: right" title="Conversions"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0658">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Cash payments</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pp0p0_c20230101__20231231_zvzznORMnkUb" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true">(415,351</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zdphX1IHcam" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true">(415,351</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashPayments_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zKUlsSg5hawe" style="text-align: right" title="Cash payments"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Cash true up liability</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pp0p0_c20230101__20231231_zubUwcqUCfkc" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true">(584,857</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zL3kPCtpH3P" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true">(584,857</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashTrueupLiability_pdp0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_ziweHIygQkO7" style="text-align: right" title="Cash true-up liability"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Change in fair value</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231_zVLC9K3quGa7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(430,437</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zx8fE3DKmXF5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(146,479</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zCdBontZneH5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value"><span style="-sec-ix-redline: true">(283,958</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Fair value, December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231_zDPdGdn6P3D5" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--ConvertibleNotesMember_zkEkNJmTBCl7" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__custom--LiabilityClassifiedWarrantsMember_zhByIrzTdGG1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-redline: true">26,388</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 4513925 4203579 310346 -3056892 -3056892 -415351 -415351 -584857 -584857 -430437 -146479 -283958 26388 26388 5400000 3200000 2200000 1100000 5100000 2100000 3000000.0 2800000 2800000 10700000 5400000 2200000 <p id="xdx_89D_ecustom--ScheduleOfRevenueRecognitionUnderGrantsTableTextBlock_z2gBqfw9hC59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revenue recognized under the MPAR Grant and OUD Grant was as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span id="xdx_8B1_zjIiEDnrPYi8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF REVENUE RECOGNIZATION UNDER GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49D_20230101__20231231_z1VsiRJHVzf8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zihbY1zo3rC7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MPARMember_z8hKJi5tl3Z2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="-sec-ix-redline: true">MPAR</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,293,238</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">2,006,885</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TAAPOUDMember_zDxWLwQ86uAf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">TAAP/OUD</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">937,282</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">516,498</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_z5ReJrEcD379" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,230,520</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,523,383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 1293238 2006885 937282 516498 2230520 2523383 <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zjxvgdSu9t2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86B_zj7NeFf32QC6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research and Development Costs</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s research and development expenses consist primarily of third-party research and development expenses, consulting expenses, animal and clinical studies, and any allocable direct overhead, including facilities and depreciation costs, as well as salaries, payroll taxes, and employee benefits for those individuals directly involved in ongoing research and development efforts. Research and development expenses are charged to expense as incurred. Payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_849_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_za3Hl2QNiycb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_868_zMYsaywsk0B7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General and Administrative Expenses</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses consist primarily of personnel costs associated with the Company’s executive, finance, human resources, compliance, and other administrative personnel, as well as accounting and legal professional services fees.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zJrxNq5aQDdb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86E_zDAAeb5rTcCc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based Compensation</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses stock-based compensation over the requisite service period based on the estimated grant-date fair value of the awards using a graded amortization approach. The Company accounts for forfeitures as they occur.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. Stock-based compensation costs are recorded in research and development and general and administrative expenses in the consolidated statements of operations.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time-to-time equity classified awards may be modified. On the modification date, the Company estimates the fair value of the awards immediately before and immediately after modification. The incremental increase in fair value is recognized as expense immediately to the extent the underlying equity awards are vested and on a straight-line basis over the same remaining amortization schedule as the unvested underlying equity awards.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zLZV829S4P9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_867_zjZJzLVhm1Sk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income Taxes</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are recorded in accordance with ASC 740, <i>Income Taxes</i> (“ASC 740”), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for uncertain tax positions in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions to the extent that the benefit would more likely than not be realized assuming examination by the taxing authority. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as consideration of the available facts and circumstances. The Company recognizes any interest and penalties accrued related to unrecognized tax benefits as income tax expense.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zAEsmjUpqvIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_863_z2OHW4aKKij3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earnings per Share</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The basic earnings per share is calculated by dividing the Company’s net income or loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. The diluted earnings per share is calculated by dividing the Company’s net earnings attributable to common stockholders by the diluted weighted average number of common shares outstanding during the period, determined using the treasury stock method and the average stock price during the period.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z0O50at2iEtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted average shares have been excluded from the calculations of diluted weighted average common shares outstanding because they would have been anti-dilutive (the Company has utilized the principal balance outstanding and the end of period conversion price for the Convertible Notes for the purposes of the weighted average share calculation below):</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zHJxsQHl9Njh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF WEIGHTED AVERAGE SHARES OF ANTI-DILUTIVE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_zsW02oHUl7jd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zP9SWZK01P3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zoezbNkhvHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Stock options</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">131,767</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,302</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zYNcrrBMScpf" style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">RSUs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0734">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,772</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zb1dqpvHrTNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Warrants</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,798,114</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">138,485</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zRGLfY0uv0Ec" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Convertible Notes</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">1,171,292</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">73,326</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zawwYHI5bfge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">5,101,173</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">241,885</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z0fBAPVFRvR8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Anti-dilutive weighted average shares</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">5,101,173</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">241,885</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AF_zSgY8SqW1zDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z0O50at2iEtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following weighted average shares have been excluded from the calculations of diluted weighted average common shares outstanding because they would have been anti-dilutive (the Company has utilized the principal balance outstanding and the end of period conversion price for the Convertible Notes for the purposes of the weighted average share calculation below):</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zHJxsQHl9Njh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF WEIGHTED AVERAGE SHARES OF ANTI-DILUTIVE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49A_20230101__20231231_zsW02oHUl7jd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_499_20220101__20221231_zP9SWZK01P3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year Ended December 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_404_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zoezbNkhvHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Stock options</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">131,767</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,302</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zYNcrrBMScpf" style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">RSUs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0734">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,772</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zb1dqpvHrTNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Warrants</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,798,114</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">138,485</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleDebtSecuritiesMember_zRGLfY0uv0Ec" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Convertible Notes</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">1,171,292</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">73,326</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zawwYHI5bfge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">5,101,173</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">241,885</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z0fBAPVFRvR8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Anti-dilutive weighted average shares</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">5,101,173</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">241,885</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 131767 26302 3772 3798114 138485 1171292 73326 5101173 241885 5101173 241885 <p id="xdx_840_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zBfJQDy2DZle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_86D_zjQTplf5zXIi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently Adopted Accounting Pronouncements</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Topic 470) to address issues identified as a result of the complexity with applying GAAP for certain financial instruments with characteristics of liabilities and equity. The FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock, resulting in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Certain types of convertible instruments will continue to be subject to separation models: (a) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (b) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. For convertible instruments, the contracts primarily affected are those with beneficial conversions or cash conversion features as the accounting models for those specific features have been removed. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives due to a failure to meet the settlement conditions of the derivatives scope exceptions. The FASB simplified the settlement assessment by removing the requirements to (a) consider whether the contract would be settled in registered shares, (b) to consider whether collateral is required to be posted, and (c) assess shareholder rights. The FASB also decided to enhance information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted the standard with an effective date of January 1, 2023 and the adoption did not have a significant impact on the consolidated financial statements.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zwFuRB82PnY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_865_zXUQ40R30Pd1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently Issued Accounting Pronouncements</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which sets forth improvements to the current segment disclosure requirements in accordance with Topic 280 “Segment Reporting,” including clarifying that entities with a single reportable segment are subject to both new and existing segment reporting requirements. ASU 2023-07 will be effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. Adoption of this ASU is currently being evaluated by the Company.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. ASU 2023-09 is effective for public entities with annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></span></p> <p id="xdx_80A_eus-gaap--OtherCurrentAssetsTextBlock_zEsgQfHiHiod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_820_z0CrObjbeBf3">PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_898_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_z56I4cJwAp8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets consisted of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B1_zJSTK5DlrAJd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20231231_z1lyLaFOSHOh" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_498_20221231_zQ11ie2EYvR8" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_ecustom--PrepaidResearchAndDevelopment_iI_pp0p0_maOPECzDNl_zDn3xp7Gywtg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Prepaid research and development</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">535,474</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,300,473</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PrepaidInsurance_iI_pp0p0_maOPECzDNl_zeGOpj4ahAAh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Prepaid insurance</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">441,871</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">445,583</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--OtherPrepaidExpenseCurrent_iI_pp0p0_maOPECzDNl_zfLjgRpQcJ3g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Other prepaid expenses</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">72,358</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">101,425</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_409_eus-gaap--OtherAssetsCurrent_iI_pp0p0_maOPECzDNl_zOoszD4elzL5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other current assets</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">18,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PrepaidExpenseCurrent_iTI_pp0p0_mtOPECzDNl_zEqjxegM1cf9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total prepaid expenses and other current assets</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,067,703</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,847,481</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A0_zP8CnYo3usle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_898_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_z56I4cJwAp8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets consisted of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B1_zJSTK5DlrAJd" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20231231_z1lyLaFOSHOh" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_498_20221231_zQ11ie2EYvR8" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_ecustom--PrepaidResearchAndDevelopment_iI_pp0p0_maOPECzDNl_zDn3xp7Gywtg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Prepaid research and development</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">535,474</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,300,473</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40F_eus-gaap--PrepaidInsurance_iI_pp0p0_maOPECzDNl_zeGOpj4ahAAh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Prepaid insurance</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">441,871</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">445,583</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--OtherPrepaidExpenseCurrent_iI_pp0p0_maOPECzDNl_zfLjgRpQcJ3g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Other prepaid expenses</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">72,358</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">101,425</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_409_eus-gaap--OtherAssetsCurrent_iI_pp0p0_maOPECzDNl_zOoszD4elzL5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other current assets</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">18,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_eus-gaap--PrepaidExpenseCurrent_iTI_pp0p0_mtOPECzDNl_zEqjxegM1cf9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total prepaid expenses and other current assets</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,067,703</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,847,481</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 535474 1300473 441871 445583 72358 101425 18000 1067703 1847481 <p id="xdx_80A_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zDcPy8I1O3lj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_821_zfPeSn2ZETGh">ACCRUED EXPENSES AND OTHER LIABILITIES</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRfga8n4Si47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses and other liabilities consisted of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B2_zv1cyFtkciG3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ACCRUED EXPENSES AND OTHER LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49E_20231231_zBPL2XCAiYog" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49C_20221231_z0qwzuHx6O41" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_ecustom--AccruedResearchAndDevelopment_iI_maALAOLzFDV_zUrsfEqCpZE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Accrued research and development</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">329,228</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,332,713</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_ecustom--ShareSubscriptionFacilityCommitmentsFees_iI_maALAOLzFDV_z0HfBGzIvpcg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Share subscription facility commitment fees</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">400,000</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maALAOLzFDV_z5Auavy5BD" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Professional fees</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">110,202</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">421,530</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_maALAOLzFDV_zoZIUFjU1EEk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">102,830</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">72,251</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_mtALAOLzFDV_zsXzbodZsUHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total accrued expenses and other liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">542,260</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,226,494</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A7_zgXMO5oicowe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zRfga8n4Si47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses and other liabilities consisted of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B2_zv1cyFtkciG3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ACCRUED EXPENSES AND OTHER LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49E_20231231_zBPL2XCAiYog" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49C_20221231_z0qwzuHx6O41" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2023</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"><b>2022</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_ecustom--AccruedResearchAndDevelopment_iI_maALAOLzFDV_zUrsfEqCpZE" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Accrued research and development</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">329,228</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,332,713</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_ecustom--ShareSubscriptionFacilityCommitmentsFees_iI_maALAOLzFDV_z0HfBGzIvpcg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Share subscription facility commitment fees</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">400,000</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maALAOLzFDV_z5Auavy5BD" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Professional fees</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">110,202</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">421,530</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_maALAOLzFDV_zoZIUFjU1EEk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other accrued liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">102,830</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">72,251</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_mtALAOLzFDV_zsXzbodZsUHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total accrued expenses and other liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">542,260</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">2,226,494</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 329228 1332713 400000 110202 421530 102830 72251 542260 2226494 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjnVFR5tCNe1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - <span id="xdx_82B_zzPZydkpbeI5">COMMITMENTS AND CONTINGENCIES</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchase Commitments</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company’s commitments included an estimated $<span id="xdx_90F_eus-gaap--ContractualObligation_iI_pn5n6_c20231231_zyhoZyQR1W1" title="Contractual obligation">17.9 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million related to the Company’s open purchase orders and contractual obligations that occurred in the ordinary course of business, including commitments with contract research organizations for multi-year pre-clinical and clinical research studies. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust its requirements based on its business needs prior to the delivery of goods or the performance of services.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, there were no pending legal proceedings against the Company that are expected to have a material adverse effect on cash flows, financial condition or results of operations. From time to time, the Company could become involved in disputes and various litigation matters that arise in the normal course of business. These may include disputes and lawsuits related to intellectual property, licensing, contract law and employee relations matters. Periodically, the Company reviews the status of significant matters, if any exist, and assesses its potential financial exposure. If the potential loss from any claim or legal claim is considered probable and the amount can be estimated, the Company accrues a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to pending claims and litigation.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lease</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s current lease agreement (as amended) has a term that extends through October 31, 2024 with no option to renew. As of December 31, 2023, the future lease payments totaled $<span id="xdx_900_eus-gaap--OperatingLeasePayments_c20230101__20231231_zN0cm51l1QX4" title="Future lease payments">31,249</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company recognized total rent expense of $<span id="xdx_902_eus-gaap--PaymentsForRent_c20230101__20231231_zw0ir34FaLA1" title="Rent expense">33,747</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--PaymentsForRent_c20220101__20221231_z5FAJ26diTic" title="Rent expense">31,756 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the year ended December 31, 2023, and 2022, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share Subscription Facility</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2020, the Company executed the GEM Agreement, under which an investor agreed to provide the Company with a share subscription facility of up to $<span id="xdx_903_eus-gaap--CommonStockSharesSubscriptions_iI_pn5n6_c20201231_zba3uGSOX781" title="Common stock, subscriptions value">60.0</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for a 36-month term following the public listing of the Company’s common stock. The Company controls the timing and maximum amount of drawdown under this facility and has no minimum drawdown obligation. The investor will pay, in cash, a per-share amount equal to 90% of the average daily closing price of the Company’s stock during the 30 consecutive trading days prior to the issuance of a draw notice, which shall not exceed 400% of the average trading volume for the 30 trading days immediately preceding the draw down date. Concurrent with the public listing of the Company’s shares on July 2, 2021, the Company issued to the investor <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zxU96vJOsyj6" title="Warrants issued shares">4,608 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with a three-year term to purchase common stock of Ensysce at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pp2d_c20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zJSYQQqH4led" title="Warrant, exercise price">2,402.40 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subsequently reduced to $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pp4d_c20231231__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zzb5NKecXiMd" title="Warrant, exercise price">1.5675 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at December 31, 2023 (Note 8). The Company was required to pay a commitment fee to the investor of $<span id="xdx_906_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20210601__20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zYINcIcbSaXf" title="Commitment fees">1.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million with $<span id="xdx_901_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20210601__20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--AwardDateAxis__custom--FirstAnniversaryMember_zvOSAcNkvxr5" title="Commitment fees">0.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million due on the first anniversary of the public listing date and $<span id="xdx_90F_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20210601__20210630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--AwardDateAxis__custom--EighteenMonthAnniversaryMember_zrK9Hcq6Xy44" title="Commitment fees">0.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million due on the 18-month anniversary of the public listing date. The first $<span id="xdx_90D_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20220701__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardDateAxis__custom--JulyTwentyTwentyTwoMember_zEYyvl0ETZK" title="Commitment fees">0.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the commitment fee was paid in July 2022 in common stock of the Company and the remaining $<span id="xdx_907_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20220701__20220731__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardDateAxis__custom--JanuaryTwentyTwentyThreeMember_zd50Ebf8eXbi" title="Commitment fees">0.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million was paid in January 2023 in common stock of the Company. Usage of the GEM facility is limited by other agreements of the Company. The Company has not raised any capital to date pursuant to the GEM facility.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation Subject to Shareholder Approval</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2021, the Company engaged two consultants to perform certain public and investor relations services in consideration for warrants to purchase <span id="xdx_900_ecustom--CommonStockIssuableUponExerciseWarrants_c20210701__20210731__srt--TitleOfIndividualAxis__custom--InvestorsMember_zLpCQMhpXrS5" title="Common stock issuable upon exercise warrants">2,083 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock with a five-year term and an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210731__srt--TitleOfIndividualAxis__custom--InvestorsMember_zNfWSHlgEqAd" title="Warrant, exercise price">1,507.20 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pid_c20210701__20210731__srt--TitleOfIndividualAxis__custom--InvestorsMember_zJ0kyjd9mOji" title="Shares issued, share based compensation shares">208 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock each, and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20210701__20210731__srt--TitleOfIndividualAxis__custom--InvestorsMember_zH4lce3qX0ic" title="Stock issued, restricted stock shares">833 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted stock units each. The restricted stock units vested over <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20210701__20210731__srt--TitleOfIndividualAxis__custom--InvestorsMember_ze1XwyhWK79a" title="Vesting period">one year</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20210701__20210731__srt--TitleOfIndividualAxis__custom--InvestorsMember_zzlxh6jRZU81" title="Share based payment award, vesting rights, percentage">50</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the vesting contingent upon certain market conditions. These equity awards were contingent upon shareholder approval of an amended and restated 2021 Omnibus Plan at a special shareholder meeting in January 2022, at which time the warrants were replaced by non-qualified stock options with similar terms. As the original terms of the awards did not satisfy the grant date criteria for an equity award, as of December 31, 2021, the Company recorded a liability of $<span id="xdx_90F_ecustom--ConsultantStockCompensationExpenses_iI_c20211231_z7f2Mzem8bG7" title="Consultant compensation expenses">1,342,479 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to reflect the estimated value of services received during the period. On February 14, 2022, the equity awards were granted, and the Company reclassified the outstanding liability to stockholders’ equity (See Note 9 for additional details of the Company’s stock-based compensation).</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> 17900000 31249 33747 31756 60000000.0 4608 2402.40 1.5675 1200000 800000 400000 800000 400000 2083 1507.20 208 833 P1Y 0.50 1342479 <p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zKwLLR2cXFpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 - <span id="xdx_821_zYElh3Sd3641">NOTES PAYABLE</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfDebtTableTextBlock_znBoQvjJMYn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a summary of the Company’s outstanding debt as of December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BB_zDUwHPJ8wdWh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Principal</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Accrued</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">interest</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Unamortized Debt</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Discount &amp; Issuance Costs</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Net debt</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">2023 Notes</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zyaEchiihsta" style="width: 11%; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">1,836,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zYQWy6PA9rj4" style="width: 11%; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">13,078</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_989_eus-gaap--DebtInstrumentFairValue_iNI_pp0p0_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zbeDSwhxcAdi" style="width: 11%; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">(1,197,200</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_983_eus-gaap--NotesPayable_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zIphKMTZ3V7c" style="width: 11%; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">651,878</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Financed insurance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zWFnL1TEwbl3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">197,249</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zGQH7dCHzlpg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">5,570</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98C_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zQnZmuSDnTPc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--NotesPayable_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zSya4fhZV6Ce" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">202,819</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231_z6t8eOnUjlai" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">2,033,249</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231_zIZpBX0C8bYc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">18,648</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_981_eus-gaap--DebtInstrumentFairValue_iNI_pp0p0_di_c20231231_zn4M7Mrnckjk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">(1,197,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--NotesPayable_iI_pp0p0_c20231231_ztROkXpoB6ng" style="border-bottom: Black 2.5pt double; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">854,697</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a summary of the Company’s outstanding debt as of December 31, 2022:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Principal</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Accrued</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">interest</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Fair value</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">adjustment</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Net debt</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">2022 Notes</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zB8DIN6PhBF7" style="width: 11%; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">3,905,264</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zwojz5E78VDa" style="width: 11%; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">10,544</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zMgfQ4xX7rVi" style="width: 11%; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">287,771</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98D_eus-gaap--NotesPayable_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zbnHhPEMPrK2" style="width: 11%; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Financed insurance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zlIHtnUlYn0j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">195,273</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zMe8bVbEUPE4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">7,906</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zYRSed8u2l8b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--NotesPayable_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zkSWBNPfrOFh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">203,179</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221231_zP8NlfDwKCU" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">4,100,537</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_986_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231_z3UxCpgTXLnj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">18,450</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_989_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20221231_zlz33ZwsKpyc" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">287,771</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_989_eus-gaap--NotesPayable_iI_pp0p0_c20221231_zBxF8GEWdUe2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">4,406,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A4_zx7LMrTq8GCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest expense</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The interest expense recognized for financed insurance was $<span id="xdx_908_eus-gaap--InterestExpenseDebt_c20230101__20231231_zVJYjEPnJglj" title="Interest expense">14,716 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--InterestExpenseDebt_c20220101__20221231_ztnqdptlQ8hk" title="Interest expense">9,909 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended December 31, 2023 and 2022, respectively. Interest expense recognized for the 2023 Notes was $<span id="xdx_90B_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zpTDprRrVQA2" title="Interest expense">339,230 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year-ended December 31, 2023, which consists of amortization of the debt discount and debt issuance costs and accrued interest.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021 Notes</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 24, 2021, the Company entered into an agreement with institutional investors to issue the 2021 Notes. The agreement provided for two closings: the first closing for $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn5n6_c20210924__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_z0r3TsrGPqA7" title="Convertible debt">5.3 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (resulting in net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20210923__20210924__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zEozRq1RfTe3" title="Proceeds from convertible debt">4.6 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million) which closed on September 24, 2021. The second closing for $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn5n6_c20211105__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zuefU7jufJub" title="Convertible debt">10.6 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (resulting in net proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20211104__20211105__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zNqYjPJMaINc" title="Proceeds from convertible debt">9.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million) which closed on November 5, 2021.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2021 Notes included a stated rate of interest of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zTPnOuAL6Bea" title="Debt instrument, interest rate">5</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, in addition to an original issue discount of <span id="xdx_903_ecustom--DebtInstrumentOriginalIssueDiscount_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zWBTpB5pj0Nb" title="Debt instrument original issue discount">6</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. The interest could be settled in cash or shares at the option of the Company and was payable together with monthly redemptions of the outstanding principal amount of the debt.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company elected to apply the fair value option to the measurement of the 2021 Notes. The total initial fair value of the debt at issuance was $<span id="xdx_906_eus-gaap--PaymentsOfDebtIssuanceCosts_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zHxCMtL8Owwg" title="Payments of debt issuance costs">15.9 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The fair value measurement included the assumption of accrued interest and interest expense (at the stated rate plus an <span id="xdx_90B_ecustom--PercentageOfCashSettlementPremium_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zO5LGSSCNsIb" title="Percentage of cash settlement premium">8</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% cash settlement premium). If presented separately, the total amount of interest expense (after consideration of the conversions) for the year-ended December 31, 2022 would be $<span id="xdx_903_ecustom--InterestExpenseAfterConsiderationOfConversion_pn5n6_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zhksyW4dgsal" title="Interest expense after consideration of conversion">0.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the issuance of the 2021 Notes the Company also issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210924_ze6je3tL7FOl" title="Warrants issued">1,507 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211105_zDFmxJ9JRdf7" title="Warrants issued">3,011 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants on the respective closing dates. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210924_zhC5Zz9r1pCi" title="Warrants, exercise price">1,831.20 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(subject to downward revision protection in the event the Company makes certain issuances of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210924__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember__srt--RangeAxis__srt--MinimumMember_zf812w4Qvttf" title="Warrant expiration date">September 23, 2026</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210924__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember__srt--RangeAxis__srt--MaximumMember_zNM8sjz65gJ4" title="Warrant expiration date">November 4, 2026</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. As a result of the issuance of the 2022 Notes in July 2022, the exercise price of these warrants was adjusted down to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220731__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zGHaaWFBHfPi" title="Warrants, exercise price">187.20</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwoThousandTwentyOneMember_zojEq9aw43Fk" title="Warrants exercise price">0.125 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per outstanding warrant, the Company amended the warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_z4HiPxWKOPy4" title="Warrants exercise price">3.64</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2021 Notes were settled on October 11, 2022 and were not outstanding as of December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022 Notes</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2022, the Company entered into an $<span id="xdx_901_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn5n6_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z2Jzg7iXDeLe" title="Convertible debt">8.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million convertible financing agreement with institutional investors. The agreement provided for two closings, each for notes payable of $<span id="xdx_90A_eus-gaap--NotesPayable_iI_pn4n6_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z0b4VElVBOH4" title="Notes payable">4.24 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (resulting in gross cash proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20220628__20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zbJ0Agbl9Nuh" title="Cash proceeds from issuance of debt">4.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million per closing). Funds were received for the first closing on July 1, 2022 and for the second closing on August 9, 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the issuance date, the Company assessed the probability of the potential settlement scenarios under the terms of the 2022 Notes and determined that the predominant settlement feature of the 2022 Notes was the redemption feature into shares of the Company’s common stock issuable at the lower of the conversion price or <span id="xdx_907_ecustom--DebtInstrumentConvertibleConversionPricePercent_iI_pid_dp_uPure_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeqZlFZGESDj" title="Conversion price, percent">92</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the average of the three lowest VWAPs in the 10 trading days immediately preceding the redemption date. As the predominant settlement feature of the 2022 Notes is to settle a fixed monetary amount into a variable number of shares, the 2022 Notes fell within the scope of ASC 480. Accordingly, the Company determined that the 2022 Notes should be recorded at fair value on its issuance date and remeasured as of each reporting date with the change in fair value recorded as a component of other income (expense) in the Company’s consolidated statements of operations.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company initially recorded the 2022 Notes at a fair value of $<span id="xdx_90A_eus-gaap--AssetsFairValueDisclosure_iI_pn4n6_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_ztIe62oOsLte" title="Initial fair value">12.09 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million which included a loss upon issuance of $<span id="xdx_90F_ecustom--LossOnIssuanceOfFairValue_pn5n6_c20220628__20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zziAQqDzU38h" title="Loss on issuance of fair value">3.6 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million due to the current share price at issuance exceeding the conversion price. Additionally, the Company recorded issuance costs of $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_pn5n6_c20220628__20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zy9lLLLmw9O" title="Issuance costs">1.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million representing a <span id="xdx_90F_ecustom--OriginalIssueDiscountRate_pid_dp_uPure_c20220628__20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z4XOUUkhm8H6" title="Original issue discount rate">6</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% original issue discount of $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn5n6_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zmHqBdjfUvv6" title="Original issue discount">0.5 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_902_ecustom--LegalAndInvestmentBankingFees_pn5n6_c20220628__20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zq1x2tMk3JZ4" title="Legal and investment banking fees">0.6 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of legal and investment banking fees, which are included in other income (expense) on the consolidated statement of operations. After several conversions, the Company reflected the remaining balance due as of December 31, 2022 at fair value and recognized a change in fair value of convertible notes of $<span id="xdx_901_ecustom--ChangeInFairValueOfConvertibleNotes_pn5n6_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z41yWRBeHaJ9" title="Change in fair value of convertible notes">3.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (gain) for the period ended December 31, 2022 also in other income (expense) on the consolidated statements of operations.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The December 31, 2022 fair value measurement includes the assumption of accrued interest and interest expense (at the stated rate plus an <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221231_z9g2Vi4M5lbi" title="Interest rate">8</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% cash settlement premium) and thus a separate amount is not reflected on the consolidated statements of operations. If presented separately, the amount of interest expense after consideration of the conversions would be $<span id="xdx_904_eus-gaap--ConversionOfStockAmountConverted1_pn5n6_c20220101__20221231_zR8C7pyAIJD2" title="Conversion of stock amount converted">0.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for the year ended December 31, 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with each of the first and second closings of the 2022 Notes, the Company also issued warrants to purchase <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zS01lIu93N6i" title="Warrants to purchase common stock">38,900 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock. The warrants had an original exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zJysDCYApPr1" title="Warrants exercise price">170.04 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and are exercisable for <span id="xdx_90F_eus-gaap--DebtInstrumentTerm_dp_c20220628__20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zlqe0UCS2u16" title="Debt term">five years</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">following issuance of the 2022 Notes. The issuance of these warrants required the Company to reduce the conversion price of the 2021 Notes and the exercise price of the outstanding warrants associated with the 2021 Notes to $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220630__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zgpwnCGQpzm3">187.20</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. In connection with 2023 May Offering, and in exchange for $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwoThousandTwentyOneMember_zEVhdZL1iwwk" title="Warrants exercise price">0.125 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per outstanding warrant, the exercise prices of the 2022 Notes warrants and 2021 Notes warrants were reduced to $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyOneNotesMember_zFMOHNpqFUBg" title="Exercise price">3.64 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proceeds of the 2022 Notes were used for working capital purposes subject to certain customary restrictions and are secured by the Company’s rights to its patents and licenses. The Company was restricted from issuing certain additional debt or equity without the prior written consent of the holders for certain specified periods set forth in the 2022 Notes. If, at any time while the 2022 Notes are outstanding, the Company carried out one or more capital raises in excess of $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_pn5n6_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zAPNUbOjQtnb" title="Convertible debt">5.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, the holder had the right to require the Company to use up to <span id="xdx_907_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember__srt--RangeAxis__srt--MaximumMember_zUSBR1Y0SmK7" title="Debt instrument, redemption price, percentage">20</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the gross proceeds of such transaction to redeem all or a portion of the convertible notes for an amount in cash equal to the cash Mandatory Redemption Amount (i.e., 108% of outstanding principal and unpaid interest). The Company triggered this provision in connection with the public offering of securities in December of 2022, the resulting principal payments and interest were reflected as a reduction to the outstanding balance of the 2022 Notes. The <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231_zd2ItTykGP6l" title="Interest rate">8</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% premium was paid in cash and was reflected as interest expense within the consolidated statement of operations.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2022 Notes were scheduled to mature on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember__srt--RangeAxis__srt--MinimumMember_zcpwdZELKFf3" title="Debt maturity date">December 29, 2023</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember__srt--RangeAxis__srt--MaximumMember_zjPMqBG8ThM" title="Debt maturity date">February 7, 2024</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for the first and second closings, respectively. The notes bear interest at a rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zPZjQcNzLPef" title="Debt interest rate">6</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, in addition to an original issue discount of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zuXs9xB2XhC4" title="Original issue discount rate percentage">6</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. The interest may be settled in cash or shares at the option of the Company and is payable together with monthly redemptions of the outstanding principal amount of the debt. The outstanding principal and interest balances were satisfied in March 2023.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023, the Company entered into a letter agreement to reduce the conversion price for the remaining balance of the Company’s outstanding 2022 Notes from $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230112__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zZVtoYuwhVH" title="Conversion price">24.07 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230512__us-gaap--TypeOfArrangementAxis__custom--LetterAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zZmZbTt1rk6e" title="Conversion price">9.01 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the period from January 12, 2023 until May 12, 2023.The holders converted $<span id="xdx_90B_ecustom--ConversionOfNotesPayable_iI_pn5n6_c20230112__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z5FrdD1Mza04" title="Outsatnding balance converted">3.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the outstanding balance of the 2022 Notes during 2023 and received cash true-up payments totaling $<span id="xdx_905_ecustom--CashTrueUpBeforeAgreement_iI_pn5n6_c20230112__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zVYkiFOyEKgj" title="Cash ture-up value before conversion">0.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for conversions executed before the letter agreement. Additional cash true-up payments totaling $<span id="xdx_902_ecustom--CashTrueUpAfterAgreement_iI_pn5n6_c20230112__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z5jSQJl9it62" title="Cash ture-up value after conversion">0.6 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for conversions below the adjusted price were due to be paid within 120 days from January 12, 2023, in accordance with the Letter Agreement. On May 12, 2023, the Company paid $<span id="xdx_90E_eus-gaap--NotesPayable_iI_pn5n6_c20230512_zsHUVhu622F" title="Net debt balance">0.6</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of cash for the additional true-up payments to the holders of the 2022 Notes.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023 Notes</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 23, 2023, the Company entered into a Securities Purchase Agreement (“SPA”) for an aggregate financing of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20231022__20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zLb0lcCcY8fj" title="Debt financing amount">1.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million with investors, including $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20231022__20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zQhQJJt064nb" title="Debt financing amount">0.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million with a board member. At the first closing under the SPA, which occurred on October 25, 2023, the Company issued to the investors (i) senior secured convertible promissory notes in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20231025__us-gaap--TypeOfArrangementAxis__custom--FirstClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zYwMP2GGgGDf" title="Aggregate principal amount">612,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for an aggregate purchase price of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfDebt_c20231024__20231025__us-gaap--TypeOfArrangementAxis__custom--FirstClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zT617G4EME8a" title="Aggregate purchase price">566,667 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (ii) warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231025__us-gaap--TypeOfArrangementAxis__custom--FirstClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zOdY1oajKdml" title="Warrants to purchase common shares">1,255,697 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock, par value $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231025__us-gaap--TypeOfArrangementAxis__custom--FirstClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_z8SwBFHFXFK5" title="Common stock, par value">0.0001 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share in the aggregate. At the second closing under the SPA, which occurred on November 29, 2023, the Company issued to the investors referenced above, (i) additional notes in the aggregate principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20231129__us-gaap--TypeOfArrangementAxis__custom--SecondClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zYzgExbfuBZa" title="Aggregate principal amount">1,224,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for an aggregate purchase price of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfDebt_c20231129__20231129__us-gaap--TypeOfArrangementAxis__custom--SecondClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zsMSsCzIA5Q9" title="Aggregate purchase price">1,133,333 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (i) additional warrants to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231129__us-gaap--TypeOfArrangementAxis__custom--SecondClosingSecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zZA04GiAPhDh" title="Warrants to purchase common shares">2,511,394 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the common stock in the aggregate. The notes mature on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20231129__20231129__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember__srt--RangeAxis__srt--MinimumMember_zEPBRjHhTcac" title="Debt instrument maturity date">April 25, 2024</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20231129__20231129__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember__srt--RangeAxis__srt--MaximumMember_zGLbfU3Iitgk" title="Debt instrument maturity date">May 28, 2024</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The combined notes are subject to an original issue discount of <span id="xdx_909_ecustom--DebtInstrumentOriginalIssueDiscount_pid_dp_uPure_c20231022__20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zn774oRePWXd" title="Original issue discount rate">8</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, have a term of six months from their respective date of issuance and accrue interest at the rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zQ6VDEqQPVFk" title="Debt instrument accrue interest rate">6.0</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum. The notes are convertible into common stock, at a per share conversion price equal to $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zPfXfhs9sJMe" title="Debt instrument conversion price">1.5675</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Beginning ninety days following issuance of the respective notes, the Company is obligated to redeem monthly one third of the original principal amount under the applicable note, plus accrued but unpaid interest, liquidated damages and any other amounts then owing to the holder of such note. The Company is required to pay the redemption amount in cash with a premium of <span id="xdx_90E_ecustom--DebtInstrumentRedemptionPremiumPercentage_iI_pid_dp_uPure_c20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zJWqlrs1HCP8" title="Debt instrument redemption premium percentage">10</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% or, at the election of the purchaser at any time, some or all of the principal amount and interest may be paid by conversion of shares under the note into common stock based on a conversion price equal to $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zUXvAfXt5IM4" title="Debt instrument conversion price">1.5675</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company determined the 2023 Notes are to be accounted for as conventional convertible debt as they provide for the holder an option to convert the outstanding balances into a fixed number of shares (or an equivalent amount of cash at the discretion of the Company) and the option to convert meets the definition of an exception from derivative accounting. As a result, the Company has reflected the outstanding principal amount, the remaining unamortized discount (both original issue discount and the relative fair value discount associated with the warrants discussed below) and the remaining debt issuance costs as net amount on the face of the balance sheet. The amortization of the original debt discount (approximately $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zCoU4x9S4L12" title="Amortization of debt discount premium">0.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million) and issuance costs (approximately $<span id="xdx_907_eus-gaap--AmortizationOfFinancingCosts_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zB9sR6WAV0n6" title="Amortization of financing costs">0.3 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million) will be recorded as interest expense within the consolidated statements of operations. As of December 31, 2023, approximately $<span id="xdx_90D_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_z0lZQLPystCl" title="Amortization of financing costs and discounts">0.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the original debt discount and issuance costs was amortized to interest expense.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants have an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zstjlb6Jv0Pd" title="Warrant, exercise price">1.5675</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the same as the conversion price, and are exercisable for five years following the issuance date. The warrants were equity classified as they are indexed to the Company’s stock and only settleable in shares. The warrants were initially measured at fair value using a Black-Scholes valuation model and were allocated along with the 2023 Notes using the relative fair value method. The initial fair value of $<span id="xdx_905_eus-gaap--PaymentsOfDebtIssuanceCosts_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSLMaJJjtkjb" title="Payments of debt issuance costs">1.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million allocated to the warrants was considered a debt discount and will be amortized to interest expense over the remaining term of the notes. As of December 31, 2023, approximately $<span id="xdx_902_eus-gaap--AmortizationOfFinancingCosts_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbUjrCvuohB6" title="Amortization of financing costs">0.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the discount associated with the warrants was amortized to interest expense.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financed Insurance Premiums</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company renewed and financed its directors’ and officers’ liability insurance in the amount of $<span id="xdx_906_ecustom--FinancedInsurancePremiums_pn5n6_c20230601__20230630_zqDSgXW6tBS5" title="Financed insurance premiums">0.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. Monthly payments commenced in July 2023 and are scheduled through March 2024. During the year ended December 31, 2022, the Company financed its directors’ and officers’ liability insurance in the amount of $<span id="xdx_90E_ecustom--FinancedInsurancePremiums_pn5n6_c20220101__20221231_z0lx8nclmvVg" title="Financed insurance premiums">0.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and the liability was paid in full by March 31, 2023. The Company paid a total of $<span id="xdx_90C_eus-gaap--InterestPaid_c20230101__20231231__srt--ProductOrServiceAxis__custom--FinancedInsurancePremiumsMember_zECMQQR1bakl" title="Interest paid">9,402 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in interest from inception through March 2023 when the note was paid in full. The Company incurred $<span id="xdx_909_eus-gaap--InterestExpense_c20230101__20231231__srt--ProductOrServiceAxis__custom--FinancedInsurancePremiumsMember_zpsGhMBGQbGk" title="Interest expense">14,715 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--InterestExpense_c20220101__20221231__srt--ProductOrServiceAxis__custom--FinancedInsurancePremiumsMember_zH94cz6V20i8" title="Interest expense">9,909 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of interest expense associated with the financed insurance premiums for the years ended December 31, 2023 and 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfDebtTableTextBlock_znBoQvjJMYn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a summary of the Company’s outstanding debt as of December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BB_zDUwHPJ8wdWh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Principal</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Accrued</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">interest</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Unamortized Debt</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Discount &amp; Issuance Costs</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Net debt</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">2023 Notes</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zyaEchiihsta" style="width: 11%; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">1,836,000</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zYQWy6PA9rj4" style="width: 11%; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">13,078</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_989_eus-gaap--DebtInstrumentFairValue_iNI_pp0p0_di_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zbeDSwhxcAdi" style="width: 11%; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">(1,197,200</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_983_eus-gaap--NotesPayable_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zIphKMTZ3V7c" style="width: 11%; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">651,878</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Financed insurance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zWFnL1TEwbl3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">197,249</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zGQH7dCHzlpg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">5,570</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98C_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zQnZmuSDnTPc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--NotesPayable_iI_pp0p0_c20231231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zSya4fhZV6Ce" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">202,819</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231_z6t8eOnUjlai" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">2,033,249</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231_zIZpBX0C8bYc" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">18,648</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_981_eus-gaap--DebtInstrumentFairValue_iNI_pp0p0_di_c20231231_zn4M7Mrnckjk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">(1,197,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--NotesPayable_iI_pp0p0_c20231231_ztROkXpoB6ng" style="border-bottom: Black 2.5pt double; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">854,697</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a summary of the Company’s outstanding debt as of December 31, 2022:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Principal</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Accrued</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">interest</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Fair value</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">adjustment</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Net debt</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">balance</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">2022 Notes</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98B_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zB8DIN6PhBF7" style="width: 11%; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">3,905,264</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zwojz5E78VDa" style="width: 11%; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">10,544</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zMgfQ4xX7rVi" style="width: 11%; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">287,771</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98D_eus-gaap--NotesPayable_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zbnHhPEMPrK2" style="width: 11%; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">4,203,579</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Financed insurance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zlIHtnUlYn0j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">195,273</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zMe8bVbEUPE4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">7,906</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zYRSed8u2l8b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--NotesPayable_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--FinancedInsuranceMember_zkSWBNPfrOFh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">203,179</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_984_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20221231_zP8NlfDwKCU" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal balance"><span style="-sec-ix-redline: true">4,100,537</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_986_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231_z3UxCpgTXLnj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accrued interest"><span style="-sec-ix-redline: true">18,450</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_989_eus-gaap--DebtInstrumentFairValue_iI_pp0p0_c20221231_zlz33ZwsKpyc" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value adjustment"><span style="-sec-ix-redline: true">287,771</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_989_eus-gaap--NotesPayable_iI_pp0p0_c20221231_zBxF8GEWdUe2" style="border-bottom: Black 2.5pt double; text-align: right" title="Net debt balance"><span style="-sec-ix-redline: true">4,406,758</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 1836000 13078 1197200 651878 197249 5570 202819 2033249 18648 1197200 854697 3905264 10544 287771 4203579 195273 7906 203179 4100537 18450 287771 4406758 14716 9909 339230 5300000 4600000 10600000 9400000 0.05 0.06 15900000 0.08 200000 1507 3011 1831.20 2026-09-23 2026-11-04 187.20 0.125 3.64 8000000.0 4240000 4000000.0 0.92 12090000.00 3600000 1100000 0.06 500000 600000 3100000 0.08 200000 38900 170.04 P5Y 187.20 0.125 3.64 5000000.0 0.20 0.08 2023-12-29 2024-02-07 0.06 0.06 24.07 9.01 3100000 400000 600000 600000 1800000 200000 612000 566667 1255697 0.0001 1224000 1133333 2511394 2024-04-25 2024-05-28 0.08 0.060 1.5675 0.10 1.5675 100000 300000 100000 1.5675 1100000 200000 400000 400000 9402 14715 9909 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zqZRaYfUi2fb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - <span id="xdx_82A_zNYjxKSPLtBk">STOCKHOLDERS’ EQUITY</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2021, in connection with the Business Combination, the Company amended and restated its Certificate of Incorporation to authorize <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20210630_z8Jy0nabLx5l" title="Common stock, shares authorized">150,000,000</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20210630_zKklaTTxOmm" title="Preferred stock, shares authorized">1,500,000</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock, both with par value equal to $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210630_zIerBBSXq8Bk" title="Preferred stock par value">0.0001</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. In September 2022, the Company amended and restated its Certificate of Incorporation to authorize up to a total of <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20220930_z4YJcBiGcUA4" title="Common stock, shares authorized">250,000,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. As of December 31, 2023 and 2022, there were <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zIzaukKqQoUk" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_ztdCzjxfpbcd" title="Preferred stock, shares outstanding"><span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_z5otiYkY5yjf" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zbuBM0f6FVV9" title="Preferred stock, shares outstanding">no</span></span></span></span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock issued and outstanding.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2022 December Offering</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 7, 2022, we entered into an underwriting agreement with an underwriter, pursuant to which we agreed to issue and sell (i) <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221207__20221207__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zthFt9vTbK9" title="Stock issued during period shares new issues">190,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221207__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCj7DxKvWh55" title="Common stock, par value">0.0001 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, (ii) pre-funded warrants to purchase <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20221207__20221207__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkN4AqNjptD2" title="Sale of stock number of shares issued in transaction">51,666 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and (iii) warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221207__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zEaZn15tgElf" title="Warrants to purchase shares of common stock">483,333 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to the underwriter in a public offering. In addition, the Company granted the underwriter the option, for 45 days from the closing of the offering, to purchase up to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221207__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDof0UJ3UVr8" title="Warrants outstanding">28,500 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additional shares of common stock and common warrants to purchase up to an additional <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20221207__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIjUSs0lotn6" title="Warrants outstanding">72,500 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. The Underwriter agreed to purchase the shares from the Company pursuant to at a price of $<span id="xdx_907_eus-gaap--SharePrice_iI_c20221207__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zrIADx0BWH5g" title="Share price">15.62 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In lieu of a purchase of common stock that would otherwise result in an investor’s beneficial ownership exceeding <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221207__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--InvestorOneMember_zuHlLvk3X9Gh" title="Ownership percentage">4.99</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% (or, at the election of the investor, <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221207__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--InvestorTwoMember_zP9zNGAyvOZ5" title="Ownership percentage">9.99</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) of the outstanding common stock, a pre-funded warrant was offered, each of which enables the investor to purchase one share of common stock at an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221207__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zzocy97UmaRh" title="Warrants, exercise price">0.0001</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Each pre-funded warrant was exercisable upon issuance and will expire when exercised in full (all pre-funded warrants were exercised immediately upon issuance). Each pre-funded warrant was sold with a common warrant to purchase two shares of common stock. The public purchase price of one share of common stock and accompanying common warrant to purchase two shares of Common Stock is $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221207__us-gaap--StatementEquityComponentsAxis__custom--CommonWarrantOneMember_zc5eHcn1m4Ke" title="Warrant, exercise price">16.80 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the combined purchase price of one pre-funded warrant and accompanying common warrant to purchase two shares of common stock is $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221207__us-gaap--StatementEquityComponentsAxis__custom--CommonWarrantTwoMember_z8wLcBuzLEq1" title="Warrant, exercise price">16.80</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each common warrant is exercisable immediately at an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221207__us-gaap--StatementEquityComponentsAxis__custom--CommonWarrantMember_zUL1Vhp6i9d6" title="Warrant, exercise price">16.80 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share and will expire <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20221207__us-gaap--StatementEquityComponentsAxis__custom--CommonWarrantMember_zpts7XwPSYO2" title="Warrant term">five years</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">following the date of issuance. The offering closed on December 9, 2022 and we received aggregate gross proceeds of approximately $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20221209__20221209_zjjVJrNPIiHa">4.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million from the Offering.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023 February Offering</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 2, 2023, the Company agreed to issue and sell in a registered direct offering an aggregate of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230201__20230202_zTQkOALY6ED5" title="Sale of stock number of shares issued in transaction">297,619 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company, par value $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230202_zoGhUUofSVCi" title="Common stock, par value">0.0001</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, at an offering price of $<span id="xdx_90D_ecustom--CombinedOfferingPricePerShare_iI_c20230202_zNOwmozhlFr9" title="Combined offering price">10.08</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, for gross proceeds of approximately $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20230206__20230206_z3FBJZ3mkFth" title="Gross proceeds">3.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million before the deduction of placement agent fees and related costs of $<span id="xdx_90F_eus-gaap--OtherExpenses_pn5n6_c20230206__20230206_zkv0ALmHlv2b" title="Related costs">0.3</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The closing occurred on February 6, 2023. The warrants issued in connection with the 2023 February Offering are described further below.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023 May Offering</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2023, the Company completed a public offering of an aggregate of <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230511__20230512_zti7FI6vQFBe" title="Sale of stock number of shares issued in transaction">1,800,876 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock at par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230512_zuh426YtLw26" title="Common stock, par value">0.0001</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (including pre-funded warrants in lieu thereof) at a combined offering price of $<span id="xdx_903_ecustom--CombinedOfferingPricePerShare_iI_c20230512_zNGLurQA08Jf" title="Combined offering price">3.887 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, gross proceeds from this offering were approximately $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20230511__20230512_zXiaCGi5c80a" title="Gross proceeds">7.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million before the deduction of placement agent fees and related costs of $<span id="xdx_908_eus-gaap--OtherExpenses_pn5n6_c20230511__20230512_zB1vphiDPT8g" title="Related costs">0.7</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. The warrants issued in connection with the 2023 May Offering are described further below.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the offering, the Company also agreed to amend certain existing warrants to purchase up to an aggregate of <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230512_z0BUznjyimf4" title="Warrants to purchase common shares">210,085 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock that were previously issued in September 2021 through December 2022 to purchasers in the offering at exercise prices ranging from $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20230512__srt--RangeAxis__srt--MinimumMember_zM2idSmZYI5l" title="Share price">16.80 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20230512__srt--RangeAxis__srt--MaximumMember_zXAcSVEPkVsk" title="Share price">187.20 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, such that effective upon the closing of the offering, the amended warrants had a reduced exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zMkBFgcrPhG" title="Warrant, exercise price">3.64 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share at an additional offering price of $<span id="xdx_90D_ecustom--OfferingPricePerShare_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfQ9nIQY42d3" title="Combined offering price">0.125 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per amended warrant.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8DPaNi7DV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2023, outstanding warrants to purchase shares of common stock are as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8B8_zSO7T5HlY2Yb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OUTSTANDING WARRANT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">Reference</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Underlying</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Outstanding</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Warrants</span></p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">Exercise Price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">Description</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Classification</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F44_zK16dG9H4YKa" style="text-align: center; padding-left: 1.5pt; width: 10%"><span style="-sec-ix-redline: true">(a)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember_fYSk___zdwTHilDu9m8">63,659</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember__srt--RangeAxis__srt--MinimumMember_fYSk___z1NJxuegGv04">2,400.00 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember__srt--RangeAxis__srt--MaximumMember_fYSk___zEElYGmAD4L7">2,760.00</span></span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt; width: 24%"><span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember_fYSk___zbW4fIMHOYRe">LACQ warrants</span></span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 22%; text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zdbeEyjvuhc2" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(b)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_fYik___zVrwz2hPbXkg">4,608</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_fYik___zL1TVlvnhNjc">1.57</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_901_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_fYik___zXEMDab6T8tk">Share subscription facility</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F42_zMOPjt4gV712" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(c)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_fYyk___zYuO45h7SZy4">4,518</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_fYyk___zDUvLQAEFyv8">3.64</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_90A_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_fYyk___z7wMgznrrS3a">2021 Notes</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Liability</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F46_zKNj9pvDb3cc" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(d)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFourMember_fZCk___zfNMxqGlopU4">38,900</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFourMember_fZCk___zxBIDTkmn278">3.64</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_909_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantFourMember_fZCk___zR3XBxElM7I8">2022 Notes</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Liability</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F48_zSnoNXq3OWOg" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(e)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_fZSk___znMRV7JohlA2">549,993</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember__srt--RangeAxis__srt--MinimumMember_fZSk___zOvebrtKj8Eg">3.64 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember__srt--RangeAxis__srt--MaximumMember_fZSk___zRccSYPTA0d">16.80</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_fZSk___zQd9GGlaYYG2">Public offering</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F44_zuqIOWoH7Kqb" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(f)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember_fZik___z4wHWnRW8o3k">318,451</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember__srt--RangeAxis__srt--MinimumMember_fZik___zGt5YA5hT2tc">8.58 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember__srt--RangeAxis__srt--MaximumMember_fZik___zjRGf6dWZXad">12.60</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember_fZik___zE2Cs1RPoA8i" title="Warrant description">Public offering</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4B_zQ1Um3XyvFu1" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(g)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember_fZyk___znmjBxpW3cQk">3,727,813</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember__srt--RangeAxis__srt--MinimumMember_fZyk___zTeLC2MmqSci" title="Exercise price">3.64 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember__srt--RangeAxis__srt--MaximumMember_fZyk___zkMsNylQlGDa" title="Exercise price">4.86</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_908_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember_fZyk___zH9eOZ9Ora2i" title="Warrant description">Public offering</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zdVXrUQ4dHN9" style="text-align: center; padding-bottom: 1.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(h)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantEightMember_faCk___z3Isv9huPQo2" title="Outstanding warrant">3,767,091</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantEightMember_faCk___zpeAKcd4zpl5" title="Exercise price">1.57</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_900_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantEightMember_faCk___zujJCYplLj9" title="Warrant description">2023 Notes</span></span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; font-size: 12pt; padding-bottom: 2.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zArLZfe94Ws" title="Outstanding warrant">8,475,033</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="font-size: 12pt; padding-bottom: 2.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"> </span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="font-size: 12pt; text-align: right; padding-bottom: 2.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F0A_zpSf4vj15GHj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F18_zm9RCQE7viyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2021, the Company assumed a total of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210630_zg6Vqu0z8Lxf" title="Warrants issued">78,751</span> warrants previously issued by LACQ (subsequently in December 2022 and August 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightUnissued_iI_c20221231_zF4bdSDtkI3" title="Warrants cancelled">7,782</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightUnissued_iI_c20230831_zFWkX5C739m1" title="Warrants cancelled">7,310</span> warrants, respectively, were cancelled). The warrants provide holders the right to purchase common stock at a strike price of between $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630__srt--RangeAxis__srt--MinimumMember_zzwUTuCwXPd1" title="Warrant exercise price">2,400.00</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630__srt--RangeAxis__srt--MaximumMember_zIZgniG5NzUe" title="Warrant exercise price">2,760.00</span> per share and expire <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_ecustom--WarrantsExpirationDate_dd_c20210630__20210630_zWIA8T7hsoSk" title="Warrant expiration date">June 30, 2026</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20210630_zG6n9iYcSbq" title="Warrant term">five years</span> following the completion of the Business Combination. A total of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210630__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantMember_zM0XUVMv0xTe" title="Class of warrant or right, outstanding">41,666</span> of the outstanding warrants are public warrants which trade on the OTC Pink Open Market under the ticker symbol ENSCW. The remaining <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--RemainingOfCashlessWarrantShares_pid_c20210630__20210630__us-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantMember_z98phSxjmNWh" title="Remaining of cashless warrant shares">21,993</span> warrants are private warrants with restrictions on transfer and which have the right to a cashless exercise at the option of the holder.</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 3, 2021, the Company entered into an agreement with an existing warrant holder to reduce the price of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210803__us-gaap--TypeOfArrangementAxis__us-gaap--SubscriptionArrangementMember_zGPM8tXBmub9">2,083 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants issued on June 30, 2021 from $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630_zaqNPqz6stlj" title="Warrant exercise price">2,760.00 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210803_zsRaRo5BOk81" title="Warrant exercise price">2,400.00</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F07_zulWzMyZ1Nvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F14_zUOnR2L7k3s4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 2, 2021, upon public listing of the Company’s shares, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210702_zFeFUzrIqqui" title="Warrants issued">4,608</span> three-year warrants to purchase common stock pursuant to the share subscription facility. The warrants have a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtxL_c20210702_zBeTLIr6Axa" title="Warrant term::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1185">three</span></span>-year life and an initial exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210702__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zfM36PhPDWV5" title="Warrant, exercise price">2,402.40</span> per share. </span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants have been subject to multiple exercise price reductions as required by a down round adjustment feature of the warrant, due to common stock issued at prices below the then current exercise price. The adjustments have progressed from the original exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zaHhxFWuuDje" title="Warrant exercise price">2,402.40</span> </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share to the current exercise price at December 31, 2023 of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231_zuhP3Kueb212" title="Warrant exercise price">1.5675</span> </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The difference in fair value of the existing warrant prior to the adjustment and the value of the warrant after (utilizing a Black-Scholes model) is reflected on the consolidated statement of operations as a deemed dividend.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F0D_zMbEcYVrR37g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F14_z1vpJkoQcWK5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 24, 2021 and November 5, 2021, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210924_zRhcLB4E6IH1" title="Warrants issued">1,507</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211105_zDFYwClV2AT8" title="Warrants issued">3,011</span> warrants in connection with the issuance of the 2021 Notes. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211105_zI5k8IqwdeM8" title="Warrants, exercise price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210924_zuTVVMikg3Ra" title="Warrants, exercise price">1,831.20</span></span> (subject to downward revision protection in the event the Company makes certain issuances of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210924__srt--RangeAxis__srt--MinimumMember_z9rFXm7mhNy9" title="Warrant expiration date">September 23, 2026</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210924__srt--RangeAxis__srt--MaximumMember_zuf0VOa2hph1" title="Warrant expiration date">November 4, 2026</span>, respectively. As a result of the issuance of the 2022 Notes in July 2022, the exercise price of these warrants was adjusted down to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220731__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zUQrJgXbBuCe" title="Warrants, exercise price">187.20</span>. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwoThousandTwentyOneMember_zEtB04KIZZD8" title="Warrants exercise price">0.125</span> per outstanding warrant, the Company amended the warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zwowX9hOEEw9" title="Warrant, exercise price">3.64</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td id="xdx_F09_z7uWtefCyEB8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F1E_z8AmtHAl8GB3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2022 and August 9, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220701_z2E7hpCitSs8" title="Warrants issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220809_zDj36CCWD13" title="Warrants issued">19,450</span></span> warrants each in connection with the issuance of the 2022 Notes. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220701_zYwxoV3cSxBg" title="Warrants, exercise price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220809_zPKI7BqU1If4" title="Warrants, exercise price">170.04</span></span> (subject to downward revision protection in the event the Company makes certain issuance of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220701_zY2YRHv3m97" title="Warrant expiration date">June 29, 2027</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220809_zUCfgMD41Dv9" title="Warrant expiration date">August 8, 2027</span>, respectively. As a result of the issuance of shares and warrants in connection with the December public offering, the exercise price of these warrants was adjusted down to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220701__us-gaap--DebtInstrumentAxis__custom--DecemberPublicOfferingMember_z1ImjL4ii2M5" title="Warrants, exercise price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220809__us-gaap--DebtInstrumentAxis__custom--DecemberPublicOfferingMember_zkCBMJZimwJ7" title="Warrants, exercise price">24.07</span></span>. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6kLVCUgtZgh" title="Warrants exercise price">0.125</span> per outstanding warrant, the Company amended the warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zEXQ73dm42gd" title="Warrant, exercise price">3.64</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F03_zGk2AHN0z50e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F12_zsWURHrmFRwe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 9, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221209__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrTz9dt6kVwi" title="Warrants issued">549,993</span> equity classified warrants in connection with a public offering. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221209__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zO5Xg0ugrLWc" title="Warrants, exercise price">16.80</span> (subject to downward revision protection in the event the Company makes certain issuance of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221209__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4n8tkwOPjLd" title="Warrant expiration date">December 9, 2027</span>. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMe7ShQHh55d" title="Warrants exercise price">0.125</span> per applicable warrant, the Company amended <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUYToDwSGoE3" title="Shares amended">166,667</span> of these warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zbyUfJGiH7S9" title="Warrant, exercise price">3.64</span>.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F00_zucitA6eqoJ5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F14_zFtDqQGYMYK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 6, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIMvzAGQszT5" title="Warrants issued">318,451</span> equity classified warrants in connection with a public offering. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zbDqa6tv7Fh9" title="Warrants, exercise price">8.58</span> - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zlpWZdLvXJMh" title="Warrants, exercise price">12.60</span> and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zMbhod6zourh" title="Warrant expiration date">February 2, 2028</span>, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zvl6FF6xHMg4" title="Warrant expiration date">August 7, 2028</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F0B_zx0BLsxaBoU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F15_zqy4YOrjHc03" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2hcsIe3yUv8" title="Warrants issued">3,727,813</span> equity classified warrants (series A-1, A-2 and placement agent warrants) in connection with a public offering. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zyu7O9KS290j" title="Warrants, exercise price">3.64</span> - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zcrnOXntwyq8" title="Warrants, exercise price">4.86</span> and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230512__us-gaap--StatementEquityComponentsAxis__custom--SeriesAOneWarrantMember_zjsGRfEfrQR7" title="Warrants expiration date">November 12, 2024</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230512__us-gaap--StatementEquityComponentsAxis__custom--SeriesATwoWarrantMember_zwqCyFjSf2jf" title="Warrants expiration date">May 10, 2028</span>, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230512__us-gaap--StatementEquityComponentsAxis__custom--PlacementAgentWarrantsMember_zymL3TpT3aYe" title="Warrants expiration date">May 12, 2028</span>. The Company also issued<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zOT8z94yTGI8" title="Warrants issued"> 1,451,876</span> pre-funded warrants, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_ecustom--WarrantsExercised_pid_c20230511__20230512__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zQQTupfS6Ktg" title="Warrants exercised">735,000</span> pre-funded warrants were exercised in connection with the closing of the public offering, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--WarrantsExercised_pid_c20230511__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zsBkKYzg9Qze" title="Warrants exercised">716,876</span> were exercised between the closing date and December 31, 2023. The pre-funded warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zQJACazzOnE" title="Warrants, exercise price">0.0001</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span id="xdx_F0D_zdJZ0xIQp624" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F10_zZj7mrZIykx5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 25, 2023 and November 28, 2023, the Company issued warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9LWx55IUPA7" title="Warrants issued">1,255,697</span> shares and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231128__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKBDyX9P749d" title="Warrants issued">2,511,394</span> shares, respectively. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pp4d_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zABT3yrqUcwd" title="Warrants, exercise price">1.5675</span> and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zM7j35jfFkc4" title="Warrant expiration date">October 25, 2028</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zn2DwtzZwutd" title="Warrant expiration date">November 28, 2028</span>, respectively. </span></span></td></tr> </table> <p id="xdx_8AD_z8RQlyYyJMtb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p id="xdx_890_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zO0USeAEOvel" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each warrant issued has been determined using the Black-Scholes option-pricing model. The material assumptions used in the Black-Scholes model in estimating the fair value of the warrants issued for the periods presented were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B9_zmB10sZQpQIc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF WARRANTS FAIR VALUE ESTIMATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Stock price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Expected term (years)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Volatility</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Risk free rate</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 33%; text-align: left"><span style="-sec-ix-redline: true">(a) LACQ warrants (grant date varies)</span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zX0akOFS6TH7" style="width: 11%; text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3,477.60</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zMJQrwLd6uv3">2,400.00 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_z8zSk8DgTZwl">2,760.00</span></span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 10%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zeCQgx9nh6w6">3.00</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 10%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zcauWDq7VFjl">110.0</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 10%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zz5NOCfuBjIc">0.5</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(b) Share subscription facility (grant date 7/2/21)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zRRrL0WCloR2" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3,477.60</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zfXf2Vizxokf" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">2,402.40</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210702__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zBgRHsrn2zYh">3.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zzy9dAo2ZhF7">110.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zhzOFl1VMr4g">0.5</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(b) Share subscription facility (remeasurement date varies)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__srt--RangeAxis__srt--MinimumMember_z1lIUWzbkBH5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__srt--RangeAxis__srt--MaximumMember_zkUQZdubdLbb">1,029.60</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zCFXYGfP9u1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.57 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_zeNF8QL0Tlgd">680.23</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MinimumMember_zWNnjr4NkwXb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.68 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MaximumMember_zkaRr8AnszNc">2.58</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MinimumMember_zbdai4SShDg1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91.3</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MaximumMember_zebcQaZztPGi">117.2</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MinimumMember_zI68MBkRyZQd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MaximumMember_zmnFtUNbkdVg">5.43</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(c) Liability classified warrants (grant date 9/24/21)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zKwi5kUGTYR8" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1,077.60</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zN2MH3PxP5W4" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1,831.20</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zfy6d8k4iPse">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zOGeFcMdrch3">94.1</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zok5KVd9y7w7">1.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(c) Liability classified warrants (grant date 11/5/21)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zXr3fSqlaodf" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">540.00</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zFv8HybiRKhd" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1,831.20</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zIJQbQgBBNk3">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zzJJiKcYkhM5">94.1</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zHFza0iDEbec">1.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(c) Liability classified warrants (remeasured at 12/31/23)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zNr8o8QzCNbi" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1.09</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20230930__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zKXVDZPoYiY6" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3.64</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_ziO0seBeWE8k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.75 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zfrwMqqAx5v5">3.86</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zDr21lftnVwh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124.7</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zxjn9ram0Po3">126.9</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zR1FfNoX6Zje">4.1</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(d) Liability classified warrants (grant date 7/1/22)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zTDiaqQvmfM7" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">136.80</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zdLR3pUXRWpg" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">170.04</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z9tTngYsGQ0k">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zrgYVVIDCL9k">98.9</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zF6ZtEvzuPxj">2.9</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(d) Liability classified warrants (grant date 8/9/22)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z2Jiic3ArGi8" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">127.20</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zvBYFETBdxwf" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">170.04</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z7xPeIuTyFQ3">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zcqNj8AZr7ie">102.8</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zZhAVH0a6HO">3.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(d) Liability classified warrants (remeasured at 12/31/23)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_ztIj0nk607Ud" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1.09</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zBqPxtwIp8ri" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3.64</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zDnAT1vSDyI7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Expected term years">3.50 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zlQBXp6Tidn9" title="Expected term years">3.61</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_z8z3iMrD89Rc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Estimating fair value of warrants">116.2</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z1y4D7n16155" title="Estimating fair value of warrants">116.7</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230930__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zxOS8Tm7osh7" title="Estimating fair value of warrants">3.9</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> </table> <p id="xdx_8AF_zhtvLnhxaDE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> 150000000 1500000 0.0001 250000000 0 0 0 0 190000 0.0001 51666 483333 28500 72500 15.62 0.0499 0.0999 0.0001 16.80 16.80 16.80 P5Y 4100000 297619 0.0001 10.08 3000000.0 300000 1800876 0.0001 3.887 7000000.0 700000 210085 16.80 187.20 3.64 0.125 <p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z8DPaNi7DV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2023, outstanding warrants to purchase shares of common stock are as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span id="xdx_8B8_zSO7T5HlY2Yb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF OUTSTANDING WARRANT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">Reference</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Underlying</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Outstanding</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="-sec-ix-redline: true">Warrants</span></p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">Exercise Price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">Description</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Classification</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F44_zK16dG9H4YKa" style="text-align: center; padding-left: 1.5pt; width: 10%"><span style="-sec-ix-redline: true">(a)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember_fYSk___zdwTHilDu9m8">63,659</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember__srt--RangeAxis__srt--MinimumMember_fYSk___z1NJxuegGv04">2,400.00 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember__srt--RangeAxis__srt--MaximumMember_fYSk___zEElYGmAD4L7">2,760.00</span></span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt; width: 24%"><span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantOneMember_fYSk___zbW4fIMHOYRe">LACQ warrants</span></span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 22%; text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zdbeEyjvuhc2" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(b)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_fYik___zVrwz2hPbXkg">4,608</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_fYik___zL1TVlvnhNjc">1.57</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_901_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantTwoMember_fYik___zXEMDab6T8tk">Share subscription facility</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F42_zMOPjt4gV712" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(c)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_fYyk___zYuO45h7SZy4">4,518</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_fYyk___zDUvLQAEFyv8">3.64</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_90A_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantThreeMember_fYyk___z7wMgznrrS3a">2021 Notes</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Liability</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F46_zKNj9pvDb3cc" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(d)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFourMember_fZCk___zfNMxqGlopU4">38,900</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFourMember_fZCk___zxBIDTkmn278">3.64</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_909_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantFourMember_fZCk___zR3XBxElM7I8">2022 Notes</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Liability</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F48_zSnoNXq3OWOg" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(e)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_fZSk___znMRV7JohlA2">549,993</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember__srt--RangeAxis__srt--MinimumMember_fZSk___zOvebrtKj8Eg">3.64 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember__srt--RangeAxis__srt--MaximumMember_fZSk___zRccSYPTA0d">16.80</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantFiveMember_fZSk___zQd9GGlaYYG2">Public offering</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F44_zuqIOWoH7Kqb" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(f)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember_fZik___z4wHWnRW8o3k">318,451</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember__srt--RangeAxis__srt--MinimumMember_fZik___zGt5YA5hT2tc">8.58 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember__srt--RangeAxis__srt--MaximumMember_fZik___zjRGf6dWZXad">12.60</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantSixMember_fZik___zE2Cs1RPoA8i" title="Warrant description">Public offering</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4B_zQ1Um3XyvFu1" style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(g)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember_fZyk___znmjBxpW3cQk">3,727,813</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$ <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember__srt--RangeAxis__srt--MinimumMember_fZyk___zTeLC2MmqSci" title="Exercise price">3.64 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember__srt--RangeAxis__srt--MaximumMember_fZyk___zkMsNylQlGDa" title="Exercise price">4.86</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_908_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantSevenMember_fZyk___zH9eOZ9Ora2i" title="Warrant description">Public offering</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F43_zdVXrUQ4dHN9" style="text-align: center; padding-bottom: 1.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true">(h)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantEightMember_faCk___z3Isv9huPQo2" title="Outstanding warrant">3,767,091</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityOutstandingExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__custom--WarrantEightMember_faCk___zpeAKcd4zpl5" title="Exercise price">1.57</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"><span id="xdx_900_ecustom--WarrantDescription_c20230101__20231231__us-gaap--AwardTypeAxis__custom--WarrantEightMember_faCk___zujJCYplLj9" title="Warrant description">2023 Notes</span></span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Equity</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; font-size: 12pt; padding-bottom: 2.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zArLZfe94Ws" title="Outstanding warrant">8,475,033</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt; font-size: 12pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="font-size: 12pt; padding-bottom: 2.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"> </span></td><td style="font-size: 12pt; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="font-size: 12pt; text-align: right; padding-bottom: 2.5pt; padding-left: 1.5pt"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F0A_zpSf4vj15GHj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F18_zm9RCQE7viyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2021, the Company assumed a total of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210630_zg6Vqu0z8Lxf" title="Warrants issued">78,751</span> warrants previously issued by LACQ (subsequently in December 2022 and August 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightUnissued_iI_c20221231_zF4bdSDtkI3" title="Warrants cancelled">7,782</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightUnissued_iI_c20230831_zFWkX5C739m1" title="Warrants cancelled">7,310</span> warrants, respectively, were cancelled). The warrants provide holders the right to purchase common stock at a strike price of between $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630__srt--RangeAxis__srt--MinimumMember_zzwUTuCwXPd1" title="Warrant exercise price">2,400.00</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630__srt--RangeAxis__srt--MaximumMember_zIZgniG5NzUe" title="Warrant exercise price">2,760.00</span> per share and expire <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_ecustom--WarrantsExpirationDate_dd_c20210630__20210630_zWIA8T7hsoSk" title="Warrant expiration date">June 30, 2026</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20210630_zG6n9iYcSbq" title="Warrant term">five years</span> following the completion of the Business Combination. A total of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20210630__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantMember_zM0XUVMv0xTe" title="Class of warrant or right, outstanding">41,666</span> of the outstanding warrants are public warrants which trade on the OTC Pink Open Market under the ticker symbol ENSCW. The remaining <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--RemainingOfCashlessWarrantShares_pid_c20210630__20210630__us-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantMember_z98phSxjmNWh" title="Remaining of cashless warrant shares">21,993</span> warrants are private warrants with restrictions on transfer and which have the right to a cashless exercise at the option of the holder.</span> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 3, 2021, the Company entered into an agreement with an existing warrant holder to reduce the price of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210803__us-gaap--TypeOfArrangementAxis__us-gaap--SubscriptionArrangementMember_zGPM8tXBmub9">2,083 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants issued on June 30, 2021 from $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210630_zaqNPqz6stlj" title="Warrant exercise price">2,760.00 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210803_zsRaRo5BOk81" title="Warrant exercise price">2,400.00</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F07_zulWzMyZ1Nvc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F14_zUOnR2L7k3s4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 2, 2021, upon public listing of the Company’s shares, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210702_zFeFUzrIqqui" title="Warrants issued">4,608</span> three-year warrants to purchase common stock pursuant to the share subscription facility. The warrants have a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtxL_c20210702_zBeTLIr6Axa" title="Warrant term::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1185">three</span></span>-year life and an initial exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210702__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zfM36PhPDWV5" title="Warrant, exercise price">2,402.40</span> per share. </span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants have been subject to multiple exercise price reductions as required by a down round adjustment feature of the warrant, due to common stock issued at prices below the then current exercise price. The adjustments have progressed from the original exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zaHhxFWuuDje" title="Warrant exercise price">2,402.40</span> </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share to the current exercise price at December 31, 2023 of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231_zuhP3Kueb212" title="Warrant exercise price">1.5675</span> </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The difference in fair value of the existing warrant prior to the adjustment and the value of the warrant after (utilizing a Black-Scholes model) is reflected on the consolidated statement of operations as a deemed dividend.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F0D_zMbEcYVrR37g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F14_z1vpJkoQcWK5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 24, 2021 and November 5, 2021, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210924_zRhcLB4E6IH1" title="Warrants issued">1,507</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211105_zDFYwClV2AT8" title="Warrants issued">3,011</span> warrants in connection with the issuance of the 2021 Notes. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211105_zI5k8IqwdeM8" title="Warrants, exercise price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210924_zuTVVMikg3Ra" title="Warrants, exercise price">1,831.20</span></span> (subject to downward revision protection in the event the Company makes certain issuances of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210924__srt--RangeAxis__srt--MinimumMember_z9rFXm7mhNy9" title="Warrant expiration date">September 23, 2026</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210924__srt--RangeAxis__srt--MaximumMember_zuf0VOa2hph1" title="Warrant expiration date">November 4, 2026</span>, respectively. As a result of the issuance of the 2022 Notes in July 2022, the exercise price of these warrants was adjusted down to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220731__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zUQrJgXbBuCe" title="Warrants, exercise price">187.20</span>. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwoThousandTwentyOneMember_zEtB04KIZZD8" title="Warrants exercise price">0.125</span> per outstanding warrant, the Company amended the warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zwowX9hOEEw9" title="Warrant, exercise price">3.64</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td id="xdx_F09_z7uWtefCyEB8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F1E_z8AmtHAl8GB3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2022 and August 9, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220701_z2E7hpCitSs8" title="Warrants issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220809_zDj36CCWD13" title="Warrants issued">19,450</span></span> warrants each in connection with the issuance of the 2022 Notes. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220701_zYwxoV3cSxBg" title="Warrants, exercise price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220809_zPKI7BqU1If4" title="Warrants, exercise price">170.04</span></span> (subject to downward revision protection in the event the Company makes certain issuance of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220701_zY2YRHv3m97" title="Warrant expiration date">June 29, 2027</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220809_zUCfgMD41Dv9" title="Warrant expiration date">August 8, 2027</span>, respectively. As a result of the issuance of shares and warrants in connection with the December public offering, the exercise price of these warrants was adjusted down to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220701__us-gaap--DebtInstrumentAxis__custom--DecemberPublicOfferingMember_z1ImjL4ii2M5" title="Warrants, exercise price"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220809__us-gaap--DebtInstrumentAxis__custom--DecemberPublicOfferingMember_zkCBMJZimwJ7" title="Warrants, exercise price">24.07</span></span>. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6kLVCUgtZgh" title="Warrants exercise price">0.125</span> per outstanding warrant, the Company amended the warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zEXQ73dm42gd" title="Warrant, exercise price">3.64</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F03_zGk2AHN0z50e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F12_zsWURHrmFRwe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 9, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20221209__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrTz9dt6kVwi" title="Warrants issued">549,993</span> equity classified warrants in connection with a public offering. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221209__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zO5Xg0ugrLWc" title="Warrants, exercise price">16.80</span> (subject to downward revision protection in the event the Company makes certain issuance of common stock at prices below the conversion price) and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20221209__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4n8tkwOPjLd" title="Warrant expiration date">December 9, 2027</span>. On May 12, 2023, in exchange for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMe7ShQHh55d" title="Warrants exercise price">0.125</span> per applicable warrant, the Company amended <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUYToDwSGoE3" title="Shares amended">166,667</span> of these warrants to reduce their exercise price to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512_zbyUfJGiH7S9" title="Warrant, exercise price">3.64</span>.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F00_zucitA6eqoJ5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F14_zFtDqQGYMYK1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 6, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIMvzAGQszT5" title="Warrants issued">318,451</span> equity classified warrants in connection with a public offering. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zbDqa6tv7Fh9" title="Warrants, exercise price">8.58</span> - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zlpWZdLvXJMh" title="Warrants, exercise price">12.60</span> and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zMbhod6zourh" title="Warrant expiration date">February 2, 2028</span>, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230206__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zvl6FF6xHMg4" title="Warrant expiration date">August 7, 2028</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F0B_zx0BLsxaBoU7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F15_zqy4YOrjHc03" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2hcsIe3yUv8" title="Warrants issued">3,727,813</span> equity classified warrants (series A-1, A-2 and placement agent warrants) in connection with a public offering. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zyu7O9KS290j" title="Warrants, exercise price">3.64</span> - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230512__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zcrnOXntwyq8" title="Warrants, exercise price">4.86</span> and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230512__us-gaap--StatementEquityComponentsAxis__custom--SeriesAOneWarrantMember_zjsGRfEfrQR7" title="Warrants expiration date">November 12, 2024</span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230512__us-gaap--StatementEquityComponentsAxis__custom--SeriesATwoWarrantMember_zwqCyFjSf2jf" title="Warrants expiration date">May 10, 2028</span>, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20230512__us-gaap--StatementEquityComponentsAxis__custom--PlacementAgentWarrantsMember_zymL3TpT3aYe" title="Warrants expiration date">May 12, 2028</span>. The Company also issued<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230512__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zOT8z94yTGI8" title="Warrants issued"> 1,451,876</span> pre-funded warrants, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_ecustom--WarrantsExercised_pid_c20230511__20230512__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zQQTupfS6Ktg" title="Warrants exercised">735,000</span> pre-funded warrants were exercised in connection with the closing of the public offering, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--WarrantsExercised_pid_c20230511__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zsBkKYzg9Qze" title="Warrants exercised">716,876</span> were exercised between the closing date and December 31, 2023. The pre-funded warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantMember_zQJACazzOnE" title="Warrants, exercise price">0.0001</span>.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-redline: true"><span id="xdx_F0D_zdJZ0xIQp624" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_F10_zZj7mrZIykx5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 25, 2023 and November 28, 2023, the Company issued warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9LWx55IUPA7" title="Warrants issued">1,255,697</span> shares and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231128__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zKBDyX9P749d" title="Warrants issued">2,511,394</span> shares, respectively. The warrants were immediately exercisable with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pp4d_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zABT3yrqUcwd" title="Warrants, exercise price">1.5675</span> and expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zM7j35jfFkc4" title="Warrant expiration date">October 25, 2028</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20231025__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zn2DwtzZwutd" title="Warrant expiration date">November 28, 2028</span>, respectively. </span></span></td></tr> </table> 63659 2400.00 2760.00 LACQ warrants 4608 1.57 Share subscription facility 4518 3.64 2021 Notes 38900 3.64 2022 Notes 549993 3.64 16.80 Public offering 318451 8.58 12.60 Public offering 3727813 3.64 4.86 Public offering 3767091 1.57 2023 Notes 8475033 78751 7782 7310 2400.00 2760.00 2026-06-30 P5Y 41666 21993 2083 2760.00 2400.00 4608 2402.40 2402.40 1.5675 1507 3011 1831.20 1831.20 2026-09-23 2026-11-04 187.20 0.125 3.64 19450 19450 170.04 170.04 2027-06-29 2027-08-08 24.07 24.07 0.125 3.64 549993 16.80 2027-12-09 0.125 166667 3.64 318451 8.58 12.60 2028-02-02 2028-08-07 3727813 3.64 4.86 2024-11-12 2028-05-10 2028-05-12 1451876 735000 716876 0.0001 1255697 2511394 1.5675 2028-10-25 2028-11-28 <p id="xdx_890_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_zO0USeAEOvel" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each warrant issued has been determined using the Black-Scholes option-pricing model. The material assumptions used in the Black-Scholes model in estimating the fair value of the warrants issued for the periods presented were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B9_zmB10sZQpQIc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF WARRANTS FAIR VALUE ESTIMATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Stock price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Expected term (years)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Volatility</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Risk free rate</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 33%; text-align: left"><span style="-sec-ix-redline: true">(a) LACQ warrants (grant date varies)</span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zX0akOFS6TH7" style="width: 11%; text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3,477.60</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 11%; text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zMJQrwLd6uv3">2,400.00 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_z8zSk8DgTZwl">2,760.00</span></span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 10%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zeCQgx9nh6w6">3.00</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 10%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zcauWDq7VFjl">110.0</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">%</span></td><td style="width: 1%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 10%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zz5NOCfuBjIc">0.5</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(b) Share subscription facility (grant date 7/2/21)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zRRrL0WCloR2" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3,477.60</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zfXf2Vizxokf" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">2,402.40</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210702__us-gaap--FinancialInstrumentAxis__custom--LeisureAcquisitionCorpADelawareCorporationMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zBgRHsrn2zYh">3.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zzy9dAo2ZhF7">110.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210702__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zhzOFl1VMr4g">0.5</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(b) Share subscription facility (remeasurement date varies)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__srt--RangeAxis__srt--MinimumMember_z1lIUWzbkBH5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__srt--RangeAxis__srt--MaximumMember_zkUQZdubdLbb">1,029.60</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zCFXYGfP9u1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.57 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_zeNF8QL0Tlgd">680.23</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MinimumMember_zWNnjr4NkwXb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.68 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MaximumMember_zkaRr8AnszNc">2.58</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MinimumMember_zbdai4SShDg1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91.3</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MaximumMember_zebcQaZztPGi">117.2</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MinimumMember_zI68MBkRyZQd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.04</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FinancialInstrumentAxis__custom--ShareSubscriptionFacilityMember__srt--RangeAxis__srt--MaximumMember_zmnFtUNbkdVg">5.43</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(c) Liability classified warrants (grant date 9/24/21)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zKwi5kUGTYR8" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1,077.60</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zN2MH3PxP5W4" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1,831.20</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zfy6d8k4iPse">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zOGeFcMdrch3">94.1</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210924__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zok5KVd9y7w7">1.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(c) Liability classified warrants (grant date 11/5/21)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zXr3fSqlaodf" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">540.00</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zFv8HybiRKhd" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1,831.20</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zIJQbQgBBNk3">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zzJJiKcYkhM5">94.1</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211105__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zHFza0iDEbec">1.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(c) Liability classified warrants (remeasured at 12/31/23)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zNr8o8QzCNbi" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1.09</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20230930__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zKXVDZPoYiY6" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3.64</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_ziO0seBeWE8k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.75 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zfrwMqqAx5v5">3.86</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zDr21lftnVwh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124.7</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zxjn9ram0Po3">126.9</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zR1FfNoX6Zje">4.1</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(d) Liability classified warrants (grant date 7/1/22)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zTDiaqQvmfM7" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">136.80</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zdLR3pUXRWpg" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">170.04</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z9tTngYsGQ0k">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zrgYVVIDCL9k">98.9</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220701__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zF6ZtEvzuPxj">2.9</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">(d) Liability classified warrants (grant date 8/9/22)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z2Jiic3ArGi8" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">127.20</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zvBYFETBdxwf" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">170.04</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z7xPeIuTyFQ3">5.00</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zcqNj8AZr7ie">102.8</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20220809__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsGrantDateMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zZhAVH0a6HO">3.0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">(d) Liability classified warrants (remeasured at 12/31/23)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasuredMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_ztIj0nk607Ud" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">1.09</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uUSDPShares_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zBqPxtwIp8ri" style="text-align: right" title="Estimating fair value of warrants"><span style="-sec-ix-redline: true">3.64</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zDnAT1vSDyI7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Expected term years">3.50 </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zlQBXp6Tidn9" title="Expected term years">3.61</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_z8z3iMrD89Rc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Estimating fair value of warrants">116.2</span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% - <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_z1y4D7n16155" title="Estimating fair value of warrants">116.7</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20230930__us-gaap--FinancialInstrumentAxis__custom--LiabilityClassifiedWarrantsRemeasured2Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zxOS8Tm7osh7" title="Estimating fair value of warrants">3.9</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> </table> 3477.60 2400.00 2760.00 P3Y 110.0 0.5 3477.60 2402.40 P3Y 110.0 0.5 1.13 1029.60 1.57 680.23 P0Y8M4D P2Y6M29D 91.3 117.2 1.04 5.43 1077.60 1831.20 P5Y 94.1 1.0 540.00 1831.20 P5Y 94.1 1.0 1.09 3.64 P2Y9M P3Y10M9D 124.7 126.9 4.1 136.80 170.04 P5Y 98.9 2.9 127.20 170.04 P5Y 102.8 3.0 1.09 3.64 P3Y6M P3Y7M9D 116.2 116.7 3.9 <p id="xdx_803_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zhPKmduQMAtl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 - <span id="xdx_82D_zhbUnDj1Ibsa">STOCK-BASED COMPENSATION</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Business Combination, the Company assumed the 2021 Omnibus Incentive Plan (the “2021 Omnibus Plan”), which was approved by LACQ’s board and subsequently LACQ’s stockholders at a special stockholder meeting on June 28, 2021. The 2021 Omnibus Plan provides for the conversion with existing terms of the <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember_zMS2bKKHID1j" title="Option, outstanding">18,432 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options outstanding under Former Ensysce stock plans and reserves for issuance an additional <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember_z1lDBuDo2G42" title="Stock reserved for future issuance">4,166 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares for future awards under the 2021 Omnibus Plan. No further awards may be made under the Former Ensysce stock plans.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January, 2022, the 2021 Omnibus Plan was amended and restated to include an additional <span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20220131__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember_zkpNw0HX7Dcj" title="Common stock, capital shares reserved for future issuance">12,500 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares available for future grant and to provide for future annual increases. In February 2023, the Company’s Board of Directors approved an annual increase of <span id="xdx_90A_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember_z2rwYasyUwGi" title="Common stock, capital shares reserved for future issuance">26,725 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares available for future grant. In August 2023, the Company’s stockholders approved a proposal for an increase of <span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230831__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneOmnibusIncentivePlanMember_z4LOpBdnnD29" title="Common stock, capital shares reserved for future issuance">585,796 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares available for future grant.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized within general and administrative expense stock-based compensation expense of $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zAxyN44vEbe9" title="Share based compensation expense">627,406 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zLZzVhOwJzD" title="Share based compensation expense">919,056 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended December 31, 2023 and 2022, respectively. During the year ended December 31, 2023 and 2022, the company recognized within research and development expense stock-based compensation expense of $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zpV4DOAGMFRa" title="Share based compensation expense">251,754 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zBlylx216Af9" title="Share based compensation expense">152,787</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Option Activity</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company granted stock options to purchase an aggregate of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__srt--TitleOfIndividualAxis__custom--BoardOfMembersMember_zcjtqvw2DeAj" title="Number of restricted stock granted">555,000 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to employees and members of the board of directors. The options vested immediately and have an exercise price of between $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zUL2lj8nhsna" title="Weighted average exercise price, vested or expected to vest">1.13 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20231231__srt--RangeAxis__srt--MaximumMember_zUREvLfhwRja" title="Weighted average exercise price, vested or expected to vest">1.18 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. During the year ended December 31, 2022, the Company granted stock options to purchase an aggregate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__srt--TitleOfIndividualAxis__custom--BoardOfMembersMember_z7y2rqruOHFl" title="Number of restricted stock granted">9,535 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to employees, consultants and members of the board of directors. The options vest over periods between <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zfrG6Go4CDl6" title="Option, vesting period::XDX::P0Y"><span style="-sec-ix-hidden: xdx2ixbrl1394">zero </span></span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zQ6WlsmhJLo2" title="Option, vesting period">four years</span></span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and have an exercise price of between $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zHWxW7HwyTBf" title="Weighted average exercise price, vested or expected to vest">102 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20221231__srt--RangeAxis__srt--MaximumMember_zJD1cDJxemX4" title="Weighted average exercise price, vested or expected to vest">1,507.20 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEvMO0MYA4nc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s stock option activity during the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BC_zh6fdSBIR2jb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Weighted average</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Intrinsic value</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Outstanding at December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zhJ1nYLFClz9" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"><span style="-sec-ix-redline: true">26,334</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_z2oqNpEAnQwk" style="width: 11%; text-align: right" title="Weighted average exercise price. beginning balance"><span style="-sec-ix-redline: true">707.63</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zxwx9Ltz9nH7" title="Weighted average remaining contractual term, beginning balance">6.53</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230101__20231231_zkLH0AyHhVW1" style="width: 11%; text-align: right" title="Aggregate intrinsic value, beginning balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Granted</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zuawgsmvqdg6" style="text-align: right" title="Option outstanding, granted"><span style="-sec-ix-redline: true">555,000</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_ziUYe6MDL8D1" style="text-align: right" title="Weighted average exercise price, granted"><span style="-sec-ix-redline: true">1.17</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">-</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_pp0p0_c20230101__20231231_zWv6IxRh7233" style="text-align: right" title="Aggregate intrinsic value, granted"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1416">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Exercised</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20231231_zAaqLSylqgAh" style="text-align: right" title="Option outstanding, exercised"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1418">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zhBClqMZyunh" style="text-align: right" title="Weighted average exercise price, exercised"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1420">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">-</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230101__20231231_zTjZsKUQktQ4" style="text-align: right" title="Aggregate intrinsic value, exercised"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1422">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Expired / Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_zY07r9NyXgK5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Option outstanding, expired or forfeited"><span style="-sec-ix-redline: true">(20</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z1rDMbCGkdbg" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average exercise price, expired or forfeited"><span style="-sec-ix-redline: true">770.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue_pp0p0_c20230101__20231231_ziDTrZPHLdji" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate intrinsic value, expired or forfeited"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Outstanding at December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zx6GAFxfe7d1" style="border-bottom: Black 2.5pt double; text-align: right" title="Option outstanding, ending balance"><span style="-sec-ix-redline: true">581,314</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zJwHjCDWiUUg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted average exercise price, ending balance"><span style="-sec-ix-redline: true">33.15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z50ASBBxRh68" title="Weighted average remaining contractual term, beginning balance">9.57</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230101__20231231_zsQfQ6OkDQLd" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate intrinsic value, ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1436">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Exercisable at December 31, 2023</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zr2OpTYEyAN2" style="text-align: right" title="Option, exercisable"><span style="-sec-ix-redline: true">579,733</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zeTsp1JQxwFj" style="text-align: right" title="Weighted average exercise price, exercisable"><span style="-sec-ix-redline: true">31.89</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zij28Js8cKx5" title="Weighted average remaining contractual term, exercisable">9.57</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20231231_zF5W6Q2WQGJk" style="text-align: right" title="Aggregate intrinsic value, beginning balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Vested and expected to vest</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231_zS7vnOTmxFF1" style="text-align: right" title="Option vested or expected to vest"><span style="-sec-ix-redline: true">581,314</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20231231_zdVrfjMGR3xi" style="text-align: right" title="Weighted average exercise price, vested or expected to vest"><span style="-sec-ix-redline: true">33.15</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zfRCVTtyire2" title="Weighted average remaining contractual term in years, vested and expected to vest">9.57</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pp0p0_c20231231_zCGWaGMgj2Pi" style="text-align: right" title="Aggregate intrinsic value, vested or expected to vest"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A5_zA7YocBPonfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Option Valuation</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zHRjMWsKARt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each stock option granted has been determined using the Black-Scholes option-pricing model. The material assumptions used in the Black-Scholes model in estimating the fair value of the options granted for the periods presented were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BF_z9hQkA0UJ99b" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 12pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">December 31, 2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1.5pt"><span style="-sec-ix-redline: true">Exercise price</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20231231__srt--RangeAxis__srt--MinimumMember_zQKhCXWrGDf7" title="Exercise price">1.13 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20231231__srt--RangeAxis__srt--MaximumMember_zb0CSYx4bsKi" title="Exercise price">1.18</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember_zGXyBcXk6hk8" title="Exercise price">103.20 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember_zy5BpGzbJz3i" title="Exercise price">1,507.20</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Expected stock price volatility</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zq78NI5150p4" style="font-size: 10pt" title="Expected stock price volatility, minimum">106.77</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zrGxvXX3pg61" title="Expected stock price volatility, maximum">106.82</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231_zqgml6Oot69d" style="font-size: 10pt" title="Expected stock price volatility, minimum">76.61</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231_zYE9Y03DSfj5" title="Expected stock price volatility, maximum">95.87</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Expected term (years)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zFcllFgk6Txh" title="Expected term (years)">5.00</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z0LLeJwi4WEl" style="font-size: 10pt" title="Expected term (years)">5.19</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">-<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zlHbdkt9o95j" title="Expected term (years)">10.00</span></span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Risk-free interest rate</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zUj4ozBiZiPi" style="font-size: 10pt" title="Risk-free interest rate, maximum">4.62</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zZPJoSDIhur7" title="Risk-free interest rate, minimum">4.89</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231_zdEIizajV7K1" style="font-size: 10pt" title="Risk-free interest rate, maximum">1.52</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231_zFlET1goeiDh" title="Risk-free interest rate, minimum">3.14</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Expected dividend yield</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zVBdFsNkRjM7" title="Expected dividend rate">0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zDStXfj9VPTg" title="Expected dividend rate">0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> </table> <p id="xdx_8A9_zALgZ1Qu6gbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected stock-price volatility. </i>The expected volatility is derived from the historical volatilities of comparable publicly traded companies within the Company’s industry over a period approximately equal to the expected term. The comparable companies were utilized as the Company’s stock does not have sufficient historical trading activity.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected term.</i> The expected term represents the period that the stock-based awards are expected to be outstanding. The Company’s historical share option exercise experience does not provide a reasonable basis upon which to estimate an expected term due to a lack of sufficient data. Therefore, the Company estimates the expected term for employees by using the simplified method provided by the Securities and Exchange Commission. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the options. </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Risk-free interest rate. </i>The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to the expected term.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expected dividend yield. </i>The expected dividend is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on the Company’s common stock.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted-average grant date fair value of options granted during the year ended December 31, 2023 was $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zAeHUwjpzrL6" title="Weighted-average fair value per share , grant">0.93</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The weighted-average grant date fair value of options granted during the year ended December 31, 2022 was $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zYO4guQ2Vam2" title="Weighted-average fair value per share, grant">230.89</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company had an aggregate of $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231_zIDtKo6CxtZe" title="Unrecognized stock based compensation">119,848 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of unrecognized share-based compensation cost, which is expected to be recognized over the weighted average period of <span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAveragePeriodExpectedToBeRecognized_dtY_c20230101__20231231_zg13wzSRNAy3" title="Weighted average period">1.21 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Stock Units</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_893_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_ztf2ZndbSb73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s restricted stock units activity during the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zq2EU0XYFw71" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF RESTRICTED STOCK UNITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Restricted Stock Units</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Weighted average fair value</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="-sec-ix-redline: true">Outstanding at December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhBw2MXAWT1f" style="width: 16%; text-align: right" title="Restricted stock units outstanding, beginning balance"><span style="-sec-ix-redline: true">1,003</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zywSdJgdhsT4" style="width: 16%; text-align: right" title="Weight average fair value, beginning balance"><span style="-sec-ix-redline: true">120.02</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Granted</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjnroxmihQ62" style="text-align: right" title="Restricted stock units, granted"><span style="-sec-ix-redline: true">60,000</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzIR7bxS8Dt9" style="text-align: right" title="Weight average fair value, granted"><span style="-sec-ix-redline: true">1.13</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Released</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBDsgp32Nk0g" style="text-align: right" title="Restricted stock units, released"><span style="-sec-ix-redline: true">(61,001</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zsAKJjmFFFa" style="text-align: right" title="Weight average fair value, released"><span style="-sec-ix-redline: true">3.07</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Cancelled</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhX1g4TPwDIb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Restricted stock units, cancelled"><span style="-sec-ix-redline: true">(2</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zI7ykDQIsMQd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weight average fair value, cancelled"><span style="-sec-ix-redline: true">386.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Outstanding at December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYV0k6wKL5f5" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock units outstanding, ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1516">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuIOY0yLcsn2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weight average fair value, ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1518">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A1_za9Q44Ex1ddl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated fair value of each of the Company’s restricted stock unit awards granted in 2023 was determined on the date of grant based on the closing price of the Company’s common stock on the previous trading date. The restricted stock unit awards granted in 2023 were immediately vested and there were no other valuation inputs used for the estimated fair value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shares Reserved for Future Issuance</i></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_890_ecustom--ScheduleOfCommonStockFutureIssuanceTableTextBlock_zl1GlV0puoF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares of common stock are reserved for future issuance:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B0_z4GdZmmo66Ne" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMMON STOCK FUTURE ISSUANCE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="-sec-ix-redline: true">Awards outstanding under the 2021 Omnibus Incentive Plan</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5ENMNQU1l45" style="width: 16%; text-align: right" title="Common Stock, capital shares reserved for future issuance"><span style="-sec-ix-redline: true">581,314</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Awards available for future grant under 2021 Omnibus Incentive Plan</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--StockOptionAvailableForFutureGrantUnder2021OmnibusIncentivePlanMember_zFNg9x7k66Hd" style="text-align: right" title="Common Stock, capital shares reserved for future issuance"><span style="-sec-ix-redline: true">2,112</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Warrants outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOutstandingMember_z7w6HPvWTRa2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common Stock, capital shares reserved for future issuance"><span style="-sec-ix-redline: true">8,475,033</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total shares of common stock reserved for future issuance</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231_zaTZmPjJZm59" style="border-bottom: Black 2.5pt double; text-align: right" title="Total shares of common stock reserved for future issuance"><span style="-sec-ix-redline: true">9,058,459</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A5_zkumEqOvp1Dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> 18432 4166 12500 26725 585796 627406 919056 251754 152787 555000 1.13 1.18 9535 P4Y 102 1507.20 <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zEvMO0MYA4nc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s stock option activity during the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BC_zh6fdSBIR2jb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Weighted average</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Intrinsic value</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="-sec-ix-redline: true">Outstanding at December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zhJ1nYLFClz9" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"><span style="-sec-ix-redline: true">26,334</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_z2oqNpEAnQwk" style="width: 11%; text-align: right" title="Weighted average exercise price. beginning balance"><span style="-sec-ix-redline: true">707.63</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 1%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zxwx9Ltz9nH7" title="Weighted average remaining contractual term, beginning balance">6.53</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230101__20231231_zkLH0AyHhVW1" style="width: 11%; text-align: right" title="Aggregate intrinsic value, beginning balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1410">-</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Granted</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zuawgsmvqdg6" style="text-align: right" title="Option outstanding, granted"><span style="-sec-ix-redline: true">555,000</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_ziUYe6MDL8D1" style="text-align: right" title="Weighted average exercise price, granted"><span style="-sec-ix-redline: true">1.17</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">-</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_pp0p0_c20230101__20231231_zWv6IxRh7233" style="text-align: right" title="Aggregate intrinsic value, granted"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1416">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Exercised</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20231231_zAaqLSylqgAh" style="text-align: right" title="Option outstanding, exercised"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1418">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zhBClqMZyunh" style="text-align: right" title="Weighted average exercise price, exercised"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1420">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">-</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230101__20231231_zTjZsKUQktQ4" style="text-align: right" title="Aggregate intrinsic value, exercised"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1422">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Expired / Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_zY07r9NyXgK5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Option outstanding, expired or forfeited"><span style="-sec-ix-redline: true">(20</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z1rDMbCGkdbg" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average exercise price, expired or forfeited"><span style="-sec-ix-redline: true">770.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-redline: true">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue_pp0p0_c20230101__20231231_ziDTrZPHLdji" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate intrinsic value, expired or forfeited"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Outstanding at December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zx6GAFxfe7d1" style="border-bottom: Black 2.5pt double; text-align: right" title="Option outstanding, ending balance"><span style="-sec-ix-redline: true">581,314</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zJwHjCDWiUUg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted average exercise price, ending balance"><span style="-sec-ix-redline: true">33.15</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231_z50ASBBxRh68" title="Weighted average remaining contractual term, beginning balance">9.57</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230101__20231231_zsQfQ6OkDQLd" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate intrinsic value, ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1436">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Exercisable at December 31, 2023</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zr2OpTYEyAN2" style="text-align: right" title="Option, exercisable"><span style="-sec-ix-redline: true">579,733</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zeTsp1JQxwFj" style="text-align: right" title="Weighted average exercise price, exercisable"><span style="-sec-ix-redline: true">31.89</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zij28Js8cKx5" title="Weighted average remaining contractual term, exercisable">9.57</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20231231_zF5W6Q2WQGJk" style="text-align: right" title="Aggregate intrinsic value, beginning balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Vested and expected to vest</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231_zS7vnOTmxFF1" style="text-align: right" title="Option vested or expected to vest"><span style="-sec-ix-redline: true">581,314</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iI_c20231231_zdVrfjMGR3xi" style="text-align: right" title="Weighted average exercise price, vested or expected to vest"><span style="-sec-ix-redline: true">33.15</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zfRCVTtyire2" title="Weighted average remaining contractual term in years, vested and expected to vest">9.57</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pp0p0_c20231231_zCGWaGMgj2Pi" style="text-align: right" title="Aggregate intrinsic value, vested or expected to vest"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 26334 707.63 P6Y6M10D 555000 1.17 20 770.40 581314 33.15 P9Y6M25D 579733 31.89 P9Y6M25D 581314 33.15 P9Y6M25D <p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zHRjMWsKARt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each stock option granted has been determined using the Black-Scholes option-pricing model. The material assumptions used in the Black-Scholes model in estimating the fair value of the options granted for the periods presented were as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BF_z9hQkA0UJ99b" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 12pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true">December 31, 2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1.5pt"><span style="-sec-ix-redline: true">Exercise price</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20231231__srt--RangeAxis__srt--MinimumMember_zQKhCXWrGDf7" title="Exercise price">1.13 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20231231__srt--RangeAxis__srt--MaximumMember_zb0CSYx4bsKi" title="Exercise price">1.18</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-size: 10pt">$<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20221231__srt--RangeAxis__srt--MinimumMember_zGXyBcXk6hk8" title="Exercise price">103.20 </span></span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">- <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20221231__srt--RangeAxis__srt--MaximumMember_zy5BpGzbJz3i" title="Exercise price">1,507.20</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Expected stock price volatility</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_zq78NI5150p4" style="font-size: 10pt" title="Expected stock price volatility, minimum">106.77</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zrGxvXX3pg61" title="Expected stock price volatility, maximum">106.82</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20220101__20221231_zqgml6Oot69d" style="font-size: 10pt" title="Expected stock price volatility, minimum">76.61</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20220101__20221231_zYE9Y03DSfj5" title="Expected stock price volatility, maximum">95.87</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Expected term (years)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zFcllFgk6Txh" title="Expected term (years)">5.00</span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z0LLeJwi4WEl" style="font-size: 10pt" title="Expected term (years)">5.19</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">-<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zlHbdkt9o95j" title="Expected term (years)">10.00</span></span></span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Risk-free interest rate</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zUj4ozBiZiPi" style="font-size: 10pt" title="Risk-free interest rate, maximum">4.62</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zZPJoSDIhur7" title="Risk-free interest rate, minimum">4.89</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20220101__20221231_zdEIizajV7K1" style="font-size: 10pt" title="Risk-free interest rate, maximum">1.52</span></span><span style="-sec-ix-redline: true"><span style="font-size: 10pt">% - <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20220101__20221231_zFlET1goeiDh" title="Risk-free interest rate, minimum">3.14</span></span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 1.5pt"><span style="-sec-ix-redline: true">Expected dividend yield</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zVBdFsNkRjM7" title="Expected dividend rate">0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zDStXfj9VPTg" title="Expected dividend rate">0</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true">%</span></td></tr> </table> 1.13 1.18 103.20 1507.20 1.0677 1.0682 0.7661 0.9587 P5Y P5Y2M8D P10Y 0.0462 0.0489 0.0152 0.0314 0 0 0.93 230.89 119848 P1Y2M15D <p id="xdx_893_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_ztf2ZndbSb73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s restricted stock units activity during the year ended December 31, 2023:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zq2EU0XYFw71" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF RESTRICTED STOCK UNITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Restricted Stock Units</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Weighted average fair value</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%"><span style="-sec-ix-redline: true">Outstanding at December 31, 2022</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhBw2MXAWT1f" style="width: 16%; text-align: right" title="Restricted stock units outstanding, beginning balance"><span style="-sec-ix-redline: true">1,003</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zywSdJgdhsT4" style="width: 16%; text-align: right" title="Weight average fair value, beginning balance"><span style="-sec-ix-redline: true">120.02</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="-sec-ix-redline: true">Granted</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjnroxmihQ62" style="text-align: right" title="Restricted stock units, granted"><span style="-sec-ix-redline: true">60,000</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzIR7bxS8Dt9" style="text-align: right" title="Weight average fair value, granted"><span style="-sec-ix-redline: true">1.13</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Released</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zBDsgp32Nk0g" style="text-align: right" title="Restricted stock units, released"><span style="-sec-ix-redline: true">(61,001</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zsAKJjmFFFa" style="text-align: right" title="Weight average fair value, released"><span style="-sec-ix-redline: true">3.07</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Cancelled</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhX1g4TPwDIb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Restricted stock units, cancelled"><span style="-sec-ix-redline: true">(2</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zI7ykDQIsMQd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weight average fair value, cancelled"><span style="-sec-ix-redline: true">386.40</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Outstanding at December 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYV0k6wKL5f5" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted stock units outstanding, ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1516">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuIOY0yLcsn2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weight average fair value, ending balance"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1518">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 1003 120.02 60000 1.13 61001 3.07 2 386.40 <p id="xdx_890_ecustom--ScheduleOfCommonStockFutureIssuanceTableTextBlock_zl1GlV0puoF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares of common stock are reserved for future issuance:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B0_z4GdZmmo66Ne" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMMON STOCK FUTURE ISSUANCE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">December 31, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="-sec-ix-redline: true">Awards outstanding under the 2021 Omnibus Incentive Plan</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5ENMNQU1l45" style="width: 16%; text-align: right" title="Common Stock, capital shares reserved for future issuance"><span style="-sec-ix-redline: true">581,314</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Awards available for future grant under 2021 Omnibus Incentive Plan</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--StockOptionAvailableForFutureGrantUnder2021OmnibusIncentivePlanMember_zFNg9x7k66Hd" style="text-align: right" title="Common Stock, capital shares reserved for future issuance"><span style="-sec-ix-redline: true">2,112</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Warrants outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_985_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOutstandingMember_z7w6HPvWTRa2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common Stock, capital shares reserved for future issuance"><span style="-sec-ix-redline: true">8,475,033</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total shares of common stock reserved for future issuance</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td id="xdx_98B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231231_zaTZmPjJZm59" style="border-bottom: Black 2.5pt double; text-align: right" title="Total shares of common stock reserved for future issuance"><span style="-sec-ix-redline: true">9,058,459</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 581314 2112 8475033 9058459 <p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_hsrt--ConsolidatedEntitiesAxis__custom--EnsysceBiosciencesIncMember_zzuNRUikLYN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 - <span id="xdx_82D_zOIXpYZJ0amj">INCOME TAXES</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z2P2bhPPdWZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before provision for income taxes consisted of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B0_zUrxe8Q1mypf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF INCOME TAXES BENEFIT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">United States</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__country--US_z3CgEtOWRLc7" style="width: 16%; text-align: right" title="Loss before provision for income taxes"><span style="-sec-ix-redline: true">(10,626,275</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zdtRXOWoeSRl" style="width: 16%; text-align: right" title="Loss before provision for income taxes"><span style="-sec-ix-redline: true">(24,207,685</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> </table> <p id="xdx_8A6_zuCGQ93Redt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_899_ecustom--ScheduleOfFederalAndStateIncomeTaxProvisionBenefitTableTextBlock_zrS4Y0TN46P" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The federal and state income tax provision (benefit), included in general and administrative expenses in the Consolidated Statement of Operations, is summarized as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_z0TgSTVVGT3g" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FEDERAL AND STATE INCOME TAX PROVISION (BENEFIT)</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Current state provision</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_986_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_c20230101__20231231_z0QQ3xr74FJ8" style="width: 16%; text-align: right" title="Current state provision"><span style="-sec-ix-redline: true">3,200</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_980_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_c20220101__20221231_zAJE1bzYaDyc" style="width: 16%; text-align: right" title="Current state provision"><span style="-sec-ix-redline: true">1,600</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A5_zr7pO1hYbTU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zPBeKw1csrA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate of the Company’s provision (benefit) for income taxes differs from the federal statutory rate as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BF_zLhl9yXRrS32" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FEDERAL INCOME TAX RATE RECONCILIATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20230101__20231231_zmgpjpTc84c3" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_494_20220101__20221231_zDycwG7d8S93" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzN52_zPpw1Imb8T6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Income (benefit) taxes at statutory rates</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">(2,231,518</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">(5,083,614</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzN52_z9EL7hnE0Jaj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">State income tax, net of federal benefit</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(77,243</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(175,164</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_maITEBzN52_zmu3EcJokRn2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Warrants and convertible debt</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(90,392</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(234,214</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_maITEBzN52_zO2FScz3B4Rf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Nondeductible executive compensation</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">2,107</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1556">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzN52_zlOyawAjhTM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Stock based compensation</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">580,823</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">303,499</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_ecustom--IncomeTaxReconciliationShareSubscriptionFacilityTransactionCosts_maITEBzN52_zWchllGGLjmb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Share subscription facility transaction costs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1561">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">20,335</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_di_msITEBzN52_zxHepVLq4s4c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Research and development tax credits</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(629,239</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(1,028,988</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_408_eus-gaap--IncomeTaxReconciliationTaxContingencies_maITEBzN52_zNEbzufrl4Vg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Change in tax rates</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(3,848</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">54,263</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzN52_z2HlBtwvJnL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Other</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">77,162</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(78,227</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzN52_zAq8JWmsxWO6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Change in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">2,372,148</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">6,222,110</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_mtITEBzN52_znaCmumqyQVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8AB_zCpwQqUt4xne" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and (b) operating losses and tax credit carryforwards.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2s3HWWRoUDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s deferred tax assets were comprised of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zsANX9vN1Kca" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20231231_zBdp1FU8jFL8" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49C_20221231_zIXEa3qcnWt5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">As of December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Deferred tax assets:</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGz96z_zLcmxAYPzXZb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left"><span style="-sec-ix-redline: true">Net operating loss tax carryforwards</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">28,485,164</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,726,066</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pp0p0_maDTAGz96z_zsxQy2DkH7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="-sec-ix-redline: true">Tax credits</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">4,793,138</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">4,164,187</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_maDTAGz96z_zMWmiarIT5Hk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="-sec-ix-redline: true">Capitalized research costs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">4,368,767</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,729,483</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz96z_zOYo0sAOc9A8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="-sec-ix-redline: true">Stock-based compensation</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">746,444</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">1,173,158</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGz96z_zstvVjAkQ1U6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">31,279</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">265,677</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_mtDTAGz96z_maDTANzp9G_zzti52zJxqlh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross deferred tax assets</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">38,424,792</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">36,058,571</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzp9G_zjMoHQPyqZMc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(38,424,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(36,052,644</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzp9G_maDTALNzQQ7_zYVMugr3N5bh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Total deferred tax assets</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">5,927</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Deferred tax liabilities:</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0_di_maDTLzuel_ziU80ac2HBD1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1605">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(5,927</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNI_di_mtDTLzuel_msDTALNzQQ7_zOiOMdqLykqh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Total deferred tax liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1608">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(5,927</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzQQ7_z5cqeEuKKCVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1611">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1612">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A3_zkP9iMmR0plj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company had federal and California net operating loss (NOL) carryforwards of $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zcuY82FDojD5" title="Net operating loss (NOL) carryforwards">110.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20221231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--CaliforniaFranchiseTaxBoardMember_z1GqXWnGEA6c" title="Net operating loss (NOL) carryforwards">74.6 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, respectively, net of the NOLs that will expire due to Internal Revenue Code (IRC) Section 382 limitations. The federal net operating losses generated in 2018 and after of $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20181231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zLFA2zXszia7" title="Net operating losses">28.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million will <span id="xdx_908_eus-gaap--TaxCreditCarryforwardDescription_c20230101__20231231_zQumsgKV52I" title="Tax credit carryforward description">carryforward indefinitely and be available to offset up to 80% of future taxable income each year</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The federal net operating losses generated prior to 2018 of $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20171231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zzncDx1zs1r2" title="Net operating losses">82.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million will begin to expire in 2024 unless previously utilized. The California NOL carryforwards will begin to expire in 2028, unless previously utilized.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, as of December 31, 2023, the Company had federal and state research and development (R&amp;D) tax credit carryforwards of $<span id="xdx_90E_eus-gaap--TaxCreditCarryforwardAmount_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember__us-gaap--TaxCreditCarryforwardAxis__us-gaap--ResearchMember_zP0QiKT8WN0h" title="Tax credit carryforward amount">5.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_900_eus-gaap--TaxCreditCarryforwardAmount_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember__us-gaap--TaxCreditCarryforwardAxis__us-gaap--ResearchMember_zwkRNHp3oh2k" title="Tax credit carryforward amount">1.7 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, respectively. The federal tax credit carryforwards will begin to expire in 2024 unless previously utilized. The California research tax credits do not expire.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to IRC Sections 382 and 383, annual use of the Company’s NOL and R&amp;D credit carryforwards may be limited in the event that a cumulative change in ownership of more than 50% occurs within a three-year period. Although the Company has not completed an IRC Section 382/383 analysis regarding the limitation of NOL and R&amp;D credit carryforwards as of December 31, 2023, the Company estimates that approximately $<span id="xdx_907_eus-gaap--TaxCreditCarryforwardAmount_iI_pn5n6_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zeQfbAmUDqK5" title="Tax credit carryforward amount">1.5 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of tax benefits related to NOL and R&amp;D carryforwards acquired in 2015 will expire unused. Accordingly, the related NOL and R&amp;D credit carryforwards have been removed from deferred tax assets accompanied by a corresponding reduction of the valuation allowance. Due to the existence of the valuation allowance, limitations created by current and future ownership changes, if any, related to the Company’s operations in the United States will not impact its effective tax rate. Any additional ownership changes may further limit the ability to use the NOL and R&amp;D credit carryforwards.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_895_eus-gaap--SummaryOfIncomeTaxContingenciesTextBlock_zWpM0OAtLHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the activity related to the Company’s unrecognized tax benefits:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B4_zxuXwx5Yu2Bk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF INCOME TAX CONTINGENCIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20230101__20231231_zYnGOrxngzJh" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49B_20220101__20221231_zvAephZsDY15" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_407_eus-gaap--UnrecognizedTaxBenefits_iS_zJV2PS4KVyxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Balance at beginning of year</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,428,261</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,135,179</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40C_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_zvHf3Jcnv6Ra" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Increases related to current year tax positions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">128,404</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">341,108</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_404_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_zbtQnY9MebIa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Increases related to prior year tax positions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">128,695</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40D_eus-gaap--UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_zcrkOhhV6nqd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Decreases related to prior year tax positions</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">48,026</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--UnrecognizedTaxBenefits_iE_zyx0TUsgtlIa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Balance at end of year</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,685,360</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,428,261</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> <p id="xdx_8A1_z7d9OrIr0P18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the Company had unrecognized tax benefits of $<span id="xdx_908_eus-gaap--UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_iI_pn5n6_c20231231_zXNQ27wBDMu3" title="Unrecognized tax benefits that would impact effective tax rate">1.7 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and $<span id="xdx_904_eus-gaap--UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_iI_pn5n6_c20221231_zmpDqEczy9d7" title="Unrecognized tax benefits that would impact effective tax rate">1.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, respectively. Due to the existence of the valuation allowance, none of the unrecognized tax benefits would affect the effective tax rate. The Company’s policy is to recognize interest and penalties from uncertain tax positions in income tax expense. The Company did not record any interest or penalties for the years ended December 31, 2023 or 2022 and had <span id="xdx_90B_eus-gaap--FinancingReceivableAccruedInterestWriteoff_do_c20230101__20231231_zQ4j93uHgrAj" title="Financing receivable accrued interest write off"><span id="xdx_901_eus-gaap--FinancingReceivableAccruedInterestWriteoff_do_c20220101__20221231_zFA7Kfc8y5w2" title="Financing receivable accrued interest write off">no</span></span> </span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrued interest on the consolidated balance sheets as of December 31, 2023 or 2022. The Company does not anticipate that the total amount of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state jurisdictions. With few exceptions, the Company is no longer subject to United States federal income tax examinations for years before 2020 and state and local income tax examinations before 2019. However, to the extent allowed by law, the tax authorities may have the right to examine prior periods where net operating losses were generated and carried forward, and make adjustments up to the amount of the NOL carryforward amount. The Company is not currently under examination by the Internal Revenue Service or any state or local tax authority.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ensysce Biosciences, Inc.</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z2P2bhPPdWZ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before provision for income taxes consisted of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B0_zUrxe8Q1mypf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF INCOME TAXES BENEFIT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">United States</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__country--US_z3CgEtOWRLc7" style="width: 16%; text-align: right" title="Loss before provision for income taxes"><span style="-sec-ix-redline: true">(10,626,275</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__country--US_zdtRXOWoeSRl" style="width: 16%; text-align: right" title="Loss before provision for income taxes"><span style="-sec-ix-redline: true">(24,207,685</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> </table> -10626275 -24207685 <p id="xdx_899_ecustom--ScheduleOfFederalAndStateIncomeTaxProvisionBenefitTableTextBlock_zrS4Y0TN46P" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The federal and state income tax provision (benefit), included in general and administrative expenses in the Consolidated Statement of Operations, is summarized as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BE_z0TgSTVVGT3g" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FEDERAL AND STATE INCOME TAX PROVISION (BENEFIT)</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Current state provision</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_986_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_c20230101__20231231_z0QQ3xr74FJ8" style="width: 16%; text-align: right" title="Current state provision"><span style="-sec-ix-redline: true">3,200</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td id="xdx_980_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_c20220101__20221231_zAJE1bzYaDyc" style="width: 16%; text-align: right" title="Current state provision"><span style="-sec-ix-redline: true">1,600</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 3200 1600 <p id="xdx_890_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zPBeKw1csrA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effective tax rate of the Company’s provision (benefit) for income taxes differs from the federal statutory rate as follows:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BF_zLhl9yXRrS32" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF FEDERAL INCOME TAX RATE RECONCILIATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20230101__20231231_zmgpjpTc84c3" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_494_20220101__20221231_zDycwG7d8S93" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzN52_zPpw1Imb8T6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Income (benefit) taxes at statutory rates</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">(2,231,518</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">(5,083,614</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzN52_z9EL7hnE0Jaj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">State income tax, net of federal benefit</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(77,243</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(175,164</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_maITEBzN52_zmu3EcJokRn2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Warrants and convertible debt</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(90,392</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(234,214</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_maITEBzN52_zO2FScz3B4Rf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Nondeductible executive compensation</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">2,107</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1556">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzN52_zlOyawAjhTM4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Stock based compensation</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">580,823</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">303,499</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_403_ecustom--IncomeTaxReconciliationShareSubscriptionFacilityTransactionCosts_maITEBzN52_zWchllGGLjmb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Share subscription facility transaction costs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1561">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">20,335</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationTaxCreditsResearch_iN_di_msITEBzN52_zxHepVLq4s4c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Research and development tax credits</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(629,239</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(1,028,988</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_408_eus-gaap--IncomeTaxReconciliationTaxContingencies_maITEBzN52_zNEbzufrl4Vg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Change in tax rates</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(3,848</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">54,263</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzN52_z2HlBtwvJnL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true">Other</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">77,162</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">(78,227</span></td><td style="text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzN52_zAq8JWmsxWO6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Change in valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">2,372,148</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">6,222,110</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_mtITEBzN52_znaCmumqyQVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Total</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1577">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> -2231518 -5083614 -77243 -175164 -90392 -234214 2107 580823 303499 20335 629239 1028988 -3848 54263 77162 -78227 2372148 6222110 <p id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z2s3HWWRoUDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s deferred tax assets were comprised of the following:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8BD_zsANX9vN1Kca" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_491_20231231_zBdp1FU8jFL8" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49C_20221231_zIXEa3qcnWt5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">As of December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Deferred tax assets:</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGz96z_zLcmxAYPzXZb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left"><span style="-sec-ix-redline: true">Net operating loss tax carryforwards</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">28,485,164</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">26,726,066</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pp0p0_maDTAGz96z_zsxQy2DkH7nd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="-sec-ix-redline: true">Tax credits</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">4,793,138</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">4,164,187</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_maDTAGz96z_zMWmiarIT5Hk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"><span style="-sec-ix-redline: true">Capitalized research costs</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">4,368,767</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">3,729,483</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz96z_zOYo0sAOc9A8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="-sec-ix-redline: true">Stock-based compensation</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">746,444</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">1,173,158</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGz96z_zstvVjAkQ1U6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">31,279</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">265,677</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0_mtDTAGz96z_maDTANzp9G_zzti52zJxqlh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="-sec-ix-redline: true"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross deferred tax assets</span></span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">38,424,792</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">36,058,571</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzp9G_zjMoHQPyqZMc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Valuation allowance</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(38,424,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(36,052,644</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzp9G_maDTALNzQQ7_zYVMugr3N5bh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Total deferred tax assets</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">5,927</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Deferred tax liabilities:</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0_di_maDTLzuel_ziU80ac2HBD1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Other</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1605">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(5,927</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilities_iNI_di_mtDTLzuel_msDTALNzQQ7_zOiOMdqLykqh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Total deferred tax liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1608">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">(5,927</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true">)</span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pp0p0_mtDTALNzQQ7_z5cqeEuKKCVd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1611">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1612">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 28485164 26726066 4793138 4164187 4368767 3729483 746444 1173158 31279 265677 38424792 36058571 38424792 36052644 5927 5927 5927 110800000 74600000 28400000 carryforward indefinitely and be available to offset up to 80% of future taxable income each year 82400000 5100000 1700000 1500000 <p id="xdx_895_eus-gaap--SummaryOfIncomeTaxContingenciesTextBlock_zWpM0OAtLHJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the activity related to the Company’s unrecognized tax benefits:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_8B4_zxuXwx5Yu2Bk" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF INCOME TAX CONTINGENCIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_497_20230101__20231231_zYnGOrxngzJh" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" id="xdx_49B_20220101__20221231_zvAephZsDY15" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; padding-bottom: 1.5pt; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">Year ending December 31,</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2023</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span style="-sec-ix-redline: true">2022</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_407_eus-gaap--UnrecognizedTaxBenefits_iS_zJV2PS4KVyxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="-sec-ix-redline: true">Balance at beginning of year</span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,428,261</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="width: 2%"><span style="-sec-ix-redline: true"> </span></td> <td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="width: 16%; text-align: right"><span style="-sec-ix-redline: true">1,135,179</span></td><td style="width: 1%; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40C_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_zvHf3Jcnv6Ra" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="-sec-ix-redline: true">Increases related to current year tax positions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">128,404</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">341,108</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_404_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_zbtQnY9MebIa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="-sec-ix-redline: true">Increases related to prior year tax positions</span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true">128,695</span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td><span style="-sec-ix-redline: true"> </span></td> <td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></span></td><td style="text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_40D_eus-gaap--UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_zcrkOhhV6nqd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-redline: true">Decreases related to prior year tax positions</span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 1.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-redline: true">48,026</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> <tr id="xdx_408_eus-gaap--UnrecognizedTaxBenefits_iE_zyx0TUsgtlIa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="-sec-ix-redline: true">Balance at end of year</span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,685,360</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td><td style="padding-bottom: 2.5pt"><span style="-sec-ix-redline: true"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="-sec-ix-redline: true">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-redline: true">1,428,261</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="-sec-ix-redline: true"> </span></td></tr> </table> 1428261 1135179 128404 341108 128695 48026 1685360 1428261 1700000 1400000 0 0 <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zrSMqHXUHuYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 - <span id="xdx_827_zt9k9RRYE2Mi">RELATED PARTIES</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2022, the Chief Executive Officer and a Board member transferred <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220701__20220731__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndBoardMemberMember_zRCCNoIl5HY3" title="Settlement of restricted stock units, shares">3,838 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of registered common stock to GYBL to settle $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20220701__20220731__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndBoardMemberMember_zitTWc5NpvJ5" title="Settlement of restricted stock units">0.8 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of Company obligations related to the GEM Agreement (Note 6). In October 2022, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221001__20221031_zRQwPfYTrlIh" title="Settlement of restricted stock units, shares">3,838 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of unregistered and restricted common stock were subsequently issued by the Company to the related parties as reimbursement and recognized under the consolidated statement of changes in stockholders’ deficit.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the issuance of the 2023 Notes, the Company issued to a board member a $<span id="xdx_90E_eus-gaap--SeniorLongTermNotes_iI_pn5n6_c20231023__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zafQPdGfbwGg" title="Debt financing amount">0.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million senior secured convertible promissory note and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_ecustom--WarrantOrRightExercisable_iI_pn5n6_c20231023__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zAnowhtfKn5d" title="Warrants exercisable">0.4 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million warrants exercisable for common stock at $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231023__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpZm8zHRrLA" title="Warrant, exercise price">1.5675 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> 3838 800000 3838 200000 400000 1.5675 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zOGYvRKhMGo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 - <span id="xdx_82E_zaWyndMybuPa">SUBSEQUENT EVENTS</span></b></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January and February 2024, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pn5n6_c20240131__20240131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zzYc2LwmAL3c" title="Common stock, shares issued">0.7 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of common stock in repayment of $<span id="xdx_90A_eus-gaap--RepaymentsOfConvertibleDebt_pn5n6_c20240131__20240131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_z4mxDuQEhYgl" title="Repayment of convertible debt">1.2 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of the 2023 Notes, paid cash of $<span id="xdx_90D_eus-gaap--RepaymentsOfConvertibleDebt_pn5n6_c20240131__20240201__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_z5DD1htS7gma" title="Repayment of convertible debt">1.0 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in repayment of the 2023 Notes and issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pn5n6_c20240131__20240131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zWkWJpJMgHa3" title="Common stock, shares issued">1.3 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of common stock for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--TwoThousandTwentyThreeNotesMember_zJHl91vxJJMk" title="Warrant, exercise price">2.1 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million upon exercise of warrants issued in conjunction with the 2023 Notes, as discussed in Note 7.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2024, the Company entered into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIs5ZquLzxQl" title="Warrants to purchase common shares">3,601,752 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company originally issued in May 2023, having an exercise price of $<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240228__srt--RangeAxis__srt--MinimumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEDVWJVRDEF3" title="Share price">3.637 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, at a reduced exercise price of $<span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20240228__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh1eGbJwdbEl" title="Share price">1.31 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The gross proceeds to the Company from the exercise of the warrants was approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pn5n6_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgJsgQFJFkz1" title="Warrants, exercise price">4.7 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, prior to deducting placement agent fees and offering expenses. In connection with the exercise of the warrants, new warrants were issued that are immediately exercisable for an aggregate of up to <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmLs9q8dLVo4" title="Warrants to purchase common shares">7,203,504 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCgzDIluTBRh" title="Warrants to purchase common shares">1.06 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsSEbEyBEvO3" title="Warrants to purchase common shares">3,601,752 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the new warrants will expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zutzEQIHGpnb" title="Warrant expiration date">May 12, 2028</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zD8x4uXkoquh" title="Warrants to purchase common shares">3,601,752 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the new warrants will have a term of eighteen months from the issuance date. The Company also issued to the placement agent warrants to purchase up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeocOwLBvfG2" title="Warrants exercisable">252,123 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3GXLHnKTwla" title="Exercise price">1.6375 </span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share; these warrants will expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20240228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNKna9V5wiGc" title="Warrant expiration date">May 12, 2028</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></span></p> 700000 1200000 1000000.0 1300000 2.1 3601752 3.637 1.31 4700000 7203504 1.06 3601752 2028-05-12 3601752 252123 1.6375 2028-05-12 On June 30, 2021, the Company assumed a total of 78,751 warrants previously issued by LACQ (subsequently in December 2022 and August 2023, 7,782 and 7,310 warrants, respectively, were cancelled). The warrants provide holders the right to purchase common stock at a strike price of between $2,400.00 and $2,760.00 per share and expire June 30, 2026, five years following the completion of the Business Combination. A total of 41,666 of the outstanding warrants are public warrants which trade on the OTC Pink Open Market under the ticker symbol ENSCW. The remaining 21,993 warrants are private warrants with restrictions on transfer and which have the right to a cashless exercise at the option of the holder. On July 2, 2021, upon public listing of the Company’s shares, the Company issued 4,608 three-year warrants to purchase common stock pursuant to the share subscription facility. The warrants have a three-year life and an initial exercise price of $2,402.40 per share. On September 24, 2021 and November 5, 2021, the Company issued 1,507 and 3,011 warrants in connection with the issuance of the 2021 Notes. The warrants were immediately exercisable with an exercise price of $1,831.20 (subject to downward revision protection in the event the Company makes certain issuances of common stock at prices below the conversion price) and expire on September 23, 2026 and November 4, 2026, respectively. As a result of the issuance of the 2022 Notes in July 2022, the exercise price of these warrants was adjusted down to $187.20. On May 12, 2023, in exchange for $0.125 per outstanding warrant, the Company amended the warrants to reduce their exercise price to $3.64. On July 1, 2022 and August 9, 2022, the Company issued 19,450 warrants each in connection with the issuance of the 2022 Notes. The warrants were immediately exercisable with an exercise price of $170.04 (subject to downward revision protection in the event the Company makes certain issuance of common stock at prices below the conversion price) and expire on June 29, 2027 and August 8, 2027, respectively. As a result of the issuance of shares and warrants in connection with the December public offering, the exercise price of these warrants was adjusted down to $24.07. On May 12, 2023, in exchange for $0.125 per outstanding warrant, the Company amended the warrants to reduce their exercise price to $3.64. On December 9, 2022, the Company issued 549,993 equity classified warrants in connection with a public offering. The warrants were immediately exercisable with an exercise price of $16.80 (subject to downward revision protection in the event the Company makes certain issuance of common stock at prices below the conversion price) and expire on December 9, 2027. On May 12, 2023, in exchange for $0.125 per applicable warrant, the Company amended 166,667 of these warrants to reduce their exercise price to $3.64. On February 6, 2023, the Company issued 318,451 equity classified warrants in connection with a public offering. The warrants were immediately exercisable with an exercise price of $8.58 - $12.60 and expire on February 2, 2028, and August 7, 2028. On May 12, 2023, the Company issued 3,727,813 equity classified warrants (series A-1, A-2 and placement agent warrants) in connection with a public offering. The warrants were immediately exercisable with an exercise price of $3.64 - $4.86 and expire on November 12, 2024, May 10, 2028, and May 12, 2028. The Company also issued 1,451,876 pre-funded warrants, 735,000 pre-funded warrants were exercised in connection with the closing of the public offering, 716,876 were exercised between the closing date and December 31, 2023. The pre-funded warrants were immediately exercisable with an exercise price of $0.0001. On October 25, 2023 and November 28, 2023, the Company issued warrants to purchase 1,255,697 shares and 2,511,394 shares, respectively. The warrants were immediately exercisable with an exercise price of $1.5675 and expire on October 25, 2028 and November 28, 2028, respectively.